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Abstract 
The purpose of this project was to explore nursing practice perceptions regarding the 
safe-administration of outpatient chemotherapy and establish whether a knowledge deficit 
existed in an ambulatory care setting.  Although recommendations for chemotherapy 
administration exist they are not mandatory and data suggests that contamination may still be 
occurring, due in part to inconsistent nursing compliance.  To provide a foundation for instituting 
safety improvements in the administration of chemotherapy, a mailed survey was distributed to a 
population of 68 oncology nurses in an outpatient setting to explore the disparity between 
evidence-based recommendations and actual implementation. 
The Chemotherapy Handling Questionnaire previously developed by Dr. Martha 
Polovich was utilized for the purposes of this project.  The questionnaire included scales that 
measured knowledge, barriers to using personal protective equipment, perceived risks of 
exposure, self-efficacy, the climate of workplace safety, conflict of interest and interpersonal 
influences.  Each of the survey scales were scored and Spearman‟s Correlation Coefficients were 
calculated for data analysis.  Project findings suggest that despite high levels of exposure 
knowledge and moderate levels of self-efficacy for the use of personal protective equipment, 
total precaution use of outpatient oncology nurses was still low.   
This safety improvement project has multiple implications for future research.  Nurse 
perceptions suggest that personal motivation for compliance with safe-handling standards needs 
to be revisited.  Additionally, chemotherapy administration procedures need to be assessed to 
determine which barriers to safety can be minimized or eradicated and how treatment volume 
may be reduced or organized to improve outcomes and decrease the risk for unnecessary 
chemotherapy exposure.  Qualitative survey comments urge organizational leaders to ensure that 
appropriate personal protective equipment (PPE) is readily available to nursing staff, open lines 
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of communication regarding chemotherapy safety and compliance expectations are present, and 
implications for work policy changes exist. 
This project explored nursing knowledge and perceptions of the safe administration of 
chemotherapy in outpatient settings of a multi-site clinic using the Chemotherapy Handling 
Questionnaire.  The review of this cohort‟s perceptions suggests a need for ongoing evaluation 
of the workplace environment, in order to support a climate of safety and foster a culture that 
supports the well-being of nurses, in addition to their patients and the greater public. 
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CHAPTER 1 
 
INTRODUCTION  
 
 
 Knowledge is critical to safe nursing practice in all settings, but it is especially significant 
when a knowledge deficit on the part of the nurse breaches practice and threatens personal safety 
or the safety of the patient.  Past research suggests that chemotherapy may have unintentionally 
compromised the oncology work setting for more than thirty years (Hazen, Smith-Idell, & 
Howlett, 2010).  Because oncology nurses serve at the point of care for chemotherapy 
administration in most settings, they serve as the safety net for themselves and their patients.  
Despite the alarming implications of contamination and the risks they may pose for healthcare 
workers, there are no mandatory national guidelines for employers or employees.  Present 
guidelines for chemotherapy administration are “voluntary” and only provide suggested 
recommendations.  The Occupational Safety and Health Administration is working on 
developing standards that would require employers to identify and correct workplace hazards, 
but these procedures are not mandatory at this time (National Institute for Occupational Safety 
and Health, Occupational Safety and Health Administration, & The Joint Commission, 2011).   
The purpose of this project is to explore nursing practice and perceptions regarding the 
safe administration of chemotherapy and establish whether a knowledge deficit is present among 
outpatient oncology nurses and contributing to workplace hazards.  This project aimed to qualify 
and describe the magnitude of dangers to nurse safety in a select setting associated with any lack 
of knowledge or other barriers so that suggestions can be made to mitigate correlated risks.  This 
chapter will outline the problem and provide background information related to the safe 
administration of chemotherapy by nurses in the outpatient setting.   
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 The American Society of Clinical Oncology (ASCO) and the Oncology Nursing Society 
(ONS) have developed specific safety standards for the administration of chemotherapy.  These 
standards require that each institution utilize a comprehensive educational program and monitor 
nursing competency at specific intervals (Jacobsen et al., 2012).  Unfortunately, most 
chemotherapy centers require initial education and training programs but have not developed a 
common method to evaluate nursing competency in regard to safe-handling techniques.  Given 
such, it is imperative that institutions dispensing chemotherapy initially engage staff and develop 
evaluation and safe-handling strategies that continue over time (Salpaka, 2000).   
 Although guidelines for chemotherapy administration exist and are maintained by the 
Oncology Nursing Society and the American Society of Health System Pharmacists, evidence 
suggests that work environments are still contaminated with chemotherapeutic drugs due in part 
to poor nursing compliance (Polovich & Clark, 2012).  This suggests that a gap may exist 
between evidence-based recommendations for current practice and what is actually practiced in 
the clinical setting.  According to Martin and Larson (2003), nursing adherence to safety 
guidelines has often been in question in the past and clear evidence is lacking in regard to nurses‟ 
level of knowledge and compliance with existing safe administration practices.  Also, it should 
be noted that in regard to nurse safety and the administration of chemotherapeutic agents only 
recommended guidelines have been established, not well-recognized, mandatory safety 
standards. 
 Studies also conclude that policies for the administration of potentially hazardous 
medications, such as chemotherapy, may be in place but often do not reflect current standards 
and/or may not be enforced or monitored by managerial staff (Polovich & Clark, 2012).  When 
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nurses who administer chemotherapy fail to adhere to established policies and/or fail to utilize 
appropriate personal protective equipment, they place themselves and potentially their patients at 
risk for untoward outcomes.   
 Oncology nurses who handle chemotherapy in ambulatory settings often learn early to 
protect their patients from unnecessary exposure.  However, many oncology nurses may not fully 
understand or appreciate their own health risks when administering chemotherapy in the 
outpatient setting.  Unfortunately, most policies and protocols implemented in practice are 
developed to improve the safety of patients, not personnel (Salpaka, 2000).  In fact, the 
American Society of Clinical Oncology and Oncology Nursing Society standards for 
chemotherapy administration focus on patient safety, not nursing exposure (Jacobsen et al., 
2012).  While patients in these settings experience both the risks and benefits of 
chemotherapeutic drugs, nurses only experience the potential risks of unintended exposure 
creating a critical threat to safety (National Institute for Occupational Safety and Health, 
Occupational Safety and Health Administration, & The Joint Commission, 2011).    
 The Oncology Nursing Society recommends that in order to provide quality care and 
maintain safety standards, nurses must be competent in oncology nursing practice and have an 
awareness of risks amid their workplace.  A major facet of this competency is that nurses must 
be remain educated and regularly engage in mandatory updates (Crannell, 2012). 
 Polovich and Clark (2012) pose that several barriers may be influencing the practice 
problem of unintended exposure to chemotherapy and indicate that political factors regarding 
mandatory national safety guidelines need to encourage employers to acknowledge this safety 
issue.  However, existing studies suggest that despite the existence of policies and procedures, 
contamination is likely still occurring (Polovich & Clark, 2012).  Contamination may be 
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occurring due to a lack of enforcement of existing policies or the need to update current 
guidelines posted in the workplace.   
An extensive review of comprehensive standards associated with hazardous drug 
administration and the use of personal protective equipment (PPE) may be necessary to 
determine if policies and regulations need to be updated to correspond with current evidence 
(Walton, et al., 2012).  In fact, one study explains that nurses in particular are at an increased risk 
of chemotherapy exposure due to the large amount of hazardous drugs administered in outpatient 
settings as well as the lack of enforcement of existing policies in the workplace (Friese, Himes-
Ferris, Frasier, McCullag, & Griggs, 2011).  Minimal medical surveillance of healthcare workers 
may also contribute to the lack of awareness of this practice problem.  
 According to the American Society of Health-System Pharmacists (2006), all healthcare 
workers who may be exposed to chemotherapeutic drugs should be routinely monitored in a 
surveillance program.  Yet, only 46% of outpatient and office-based sites in a recent national 
survey report that they actually provide medical monitoring (Martin & Larson, 2003).  The 
Occupational Safety and Health Administration mandates periodic surveillance of those that 
work in specialty practice areas and are at risk for exposure (Salpaka, 2000).  However, the 
National Institute for Occupational Safety and Health (2012) contends that while employers 
should provide medical surveillance for workers, blood tests and urinalysis are unnecessary.  The 
incongruence between these national organizations charged to support safety in the workplace 
suggests the need to update guidelines and calls for consistency between organizations.       
 According to Geiger-Brown and Lipscomb (2011), the condition of the work 
environment is strongly associated with the quality of care provided and the safety of the patient 
as well as the health of the workforce.  In addition to this, workplace quality is linked to the 
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health and safety outcomes of nurses (Geiger-Brown & Lipscomb).  Friese and his colleagues 
suggest the overall rate of chemotherapy exposure decreases when oncology nurses report 
adequate staffing and resources (2011).  These data substantiate the need for adequate staffing 
and resources.  The study also recognizes the role of increased staff compliance and the 
acknowledgment of practice standards regarding the protection of oncology nurses.   
 The influence of workplace conditions must be included as a factor when exploring 
occupational safety issues.  Other contributing factors to organizational system failures that may 
result in unsafe work environments include lack of awareness of one‟s surroundings; poor 
communication; and direct interruptions and distractions while preparing to administer 
chemotherapy (Ashley, Dexter, Marshall, McKenzie, Ryan & Armitage, 2011).  In addition to 
these concerns, the majority of research that addresses the work conditions of nurses 
concentrates on the hospital environment, while 38% of registered nurses do not work in hospital 
settings (Geiger-Brown & Lipscomb, 2011).  This information suggests that the inclusion of 
more environmental data across ambulatory work settings is necessary.   
 In addition to the issue of unintended workplace contamination, potential harmful effects 
are occurring in work settings “despite the reported use of safety practices” or when standards 
are breached (McDiarmid, Oliver, Roth, Rogers, & Escalante, 2010, p. 1028).  This implies that 
oncology nurses may be at substantial risk when administering chemotherapy to their patients 
and it calls for a structured evaluation of the nursing role in terms of reducing workplace 
contamination and improving environmental safety.     
 Nurses may perceive they are immune to the risks of chemotherapy exposure, as existing 
research concludes that poor compliance may be associated with a knowledge deficit and/or 
perceptions of a low probability of immediate injury (Connor & Eisenberg, 2010).  Conclusions 
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from research suggest a lack of appropriate education and experience handling chemotherapeutic 
drugs can contribute to unnecessary exposure as well (Rizalar, Tural & Altay, 2012).   
 Chemotherapy exposure and workplace contamination can occur in a variety of forms 
and health outcomes differ based on the level of contact.  Routes of exposure include drug 
inhalation; direct dermal contact with the drug; indirect contact via contaminated surfaces or 
bodily fluids; accidental injection via needle stick injury; ingestion of contaminated food or 
drink; or from hand-to-mouth actions (Polovich & Gieseker, 2011).  The most common method 
of exposure is by way of skin or mucous membrane contact which is why personal protective 
equipment is highly recommended.  However, even nurses that wear recommended protection 
can be exposed to chemotherapy when unintentionally touching contaminated surfaces with their 
bare hands.  These surfaces often include counters, floors, drug storage areas, waste containers 
and drug vials (Polovich & Gieseker, 2011). 
 Exposure to chemotherapeutic drugs is associated with many adverse outcomes for 
occupationally exposed individuals including but not limited to: contact dermatitis; 
deoxyribonucleic acid (DNA) damage; chromosomal abnormalities; fetal loss; infertility; 
preterm births; and an overall increase in one‟s personal risk for cancer (Polovich & Clark, 2012).  
Pregnant nurses are at particular risk for chemotherapy exposure and a recent study reports that 
hazardous drug exposure is associated with an increased risk of spontaneous abortion among 
oncology nurses (Lawson, et al., 2012).  A survey of experienced and certified oncology nurses 
also suggests that although perceived risk of harm and knowledge of personal protective 
equipment was high, the total use of precautions was low (Polovich & Martin, 2011).  A recent 
study that explored patterns of personal protective equipment use among oncology nurses, found 
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that those working in private practices were less likely to adhere to current safety guidelines than 
those employed elsewhere (Polovich & Martin, 2011).   
In summary, the overarching goal of this practice dissertation was to explore nursing 
practices regarding the safe administration of chemotherapy and identify whether a knowledge 
deficit was present among outpatient oncology nurses.  This information will then be used to 
develop recommendations for the site of interest that will provide insight into useful 
interventions to mitigate harm in the future.  In order to provide the most successful long term 
intervention, an assessment of knowledge must be conducted to establish if a knowledge deficit 
exists so that a site-specific plan can be developed to increase adherence to current safety 
standards. 
  This project used an established survey to assess the knowledge of safe chemotherapy 
administration among oncology nurses employed by a large, multi-site cancer and hematology 
center that served a large metropolitan area.  Collecting data from nurses working in various sites 
provided valuable information used to determine whether knowledge deficits existed and if they 
contributed to a lack of safe-handling precaution use.  Results of this survey provided 
information to facilitate the collaborative development of an educational plan with organizational 
leaders to improve strategies and address deficits.  In other words, once the survey identified the 
presence and degree of knowledge deficit the author had enough information to provide 
recommendations for a targeted intervention leading to a safer work environment in the future. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
 
 The purpose of this chapter is to provide an integrative review of literature to facilitate 
the exploration of nursing practice related to the safe administration of chemotherapy and the 
identification of possible knowledge deficits.  This review will describe the current 
understanding of chemotherapy safety in the workplace and how it corresponds to 
recommendations of current evidence.  A major focus of this paper is to use the process of 
evidence-based practice to guide the development of recommendations to improve the safety of 
oncology nurses. 
Background 
 Oncology nurses working in ambulatory settings pride themselves in their ability to 
protect their clients from unnecessary exposure to chemotherapy.  However, many health care 
professionals have misconceptions of the extent of their own risk in this environment (Fuller, 
Bain, & Sperrazza, 2007).  According to Fuller and colleagues, only 54% of surveyed nurses 
were aware of safe handling programs available in their workplace and only 30% of them 
actually read the information that was offered.  This suggests a potential knowledge deficit and 
possible lack of compliance with the National Institute for Occupational Safety and Health 
(NIOSH) recommendations (Fuller et al., 2007) identifying a significant safety concern for 
employees of oncology centers who administer chemotherapy and the general public. 
 A lack of education and the inconvenience of safety equipment may prevent many nurses 
from taking appropriate precautions for themselves (Polovich & Eisenberg, 2009).  In a study of 
inpatient and outpatient nurses, researchers found that only 31% wore protective gowns during 
the administration of chemotherapy despite the availability of personal protective equipment 
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(Martin & Larson, 2003).  This study also suggests the enforcement of protective equipment use 
through means of medical surveillance is not occurring in a manner consistent with national 
recommendations.     
  In fact, recent studies suggest that although hazardous drug policies are in place in many 
workplaces, existing practices may not reflect current recommendations for safe chemotherapy 
handling and are not enforced or monitored by managerial staff (Polovich & Clark, 2012).  The 
major issue of concern is that although these policies are in place and personal protective 
equipment (PPE) is available, nurses are not consistently taking appropriate action for their 
protection.    
 In a recent study of outpatient nurses, participants reported significant unintended skin 
and eye exposure to chemotherapy (Friese, et al., 2011).  In this study, the author concludes that 
the overall rate of exposure decreases when nurses report adequate staffing and resources (2011).  
This implies that nurse-patient ratios and workplace demands contribute to the problem of 
mishandling chemotherapy.  Therefore, these results implicate the need for adequate staffing and 
resources as well as increased staff compliance to established practice standards in order to better 
protect oncology nurses.  Other contributing factors identified in system failures that result in an 
unsafe work environment include lack of awareness of personal and public risks of exposure, 
poor communication, and direct interruptions and/or distractions while preparing to administer 
medications (Ashley, et al., 2011).   
 Gaguski (2009) provides a clinically relevant intervention related to the development of a 
chemotherapy council.  This council addresses delays in medication delivery and nurse 
unfamiliarity with certain regimens of therapy (2009).  The intervention gives staff the 
opportunity to identify current safety concerns and contribute to potential breaches in standards 
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as well as provide an opportunity to evaluate present administration methods.  This allows the 
council to develop an environment of shared governance that facilitates the development of team 
goals, identification of barriers to safe chemotherapy administration, areas needing improvement 
and prioritization of needs in the workplace (2009). 
 Other studies imply that lack of an appropriate education and lack of experience handling 
hazardous drugs also play a role in unnecessary chemotherapy exposure (Rizalar, Tural, & Altay, 
2012).  Recent literature suggests that an extensive review of comprehensive standards related to 
personal protective equipment and hazardous drug administration may be necessary to determine 
whether policies and regulations need to be updated to correspond with current evidence (Walton, 
et al., 2012).  This includes the utilization of evidence-based practice to fulfill their commitment 
to safety in the workplace (2012).  In this study, authors compared their institution‟s policy, 
determined areas of improvement and implemented necessary changes related to education, use 
of appropriate gloves and safe disposal of hazardous drugs (2012).  
 Significant misconceptions regarding the level of chemotherapy exposure and associated 
risks continue to affect the awareness of oncology nurses (Fuller, Bain, & Sperrazza, 2007).  In 
fact, the actual implementation of safe-handling strategies is described to be low despite the 
accounts of nurses reporting high levels of knowledge, self-efficacy related to administration, 
and perceptions of harm related to chemotherapy exposure (Polovich & Clark, 2012).  To 
enforce the use of recommended safe-handling techniques, medical surveillance may prove vital 
in the protection of oncology nurses.  However, one survey reports that only 46% of outpatient 
and office-based sites maintain that they provide medical monitoring (Martin & Larson, 2003).  
This correlates with other research that suggests that although the use of protective equipment 
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and its availability has increased, medical surveillance is still not consistent with national 
guidelines (Polovich & Clark, 2012). 
 The scope of this practice problem outlines the need for more information regarding the 
outpatient incorporation of chemotherapy safe-handling practices.  While several barriers may 
influence the unintended exposure to hazardous drugs, the presence of a knowledge deficit must 
first be documented and addressed prior to intervening further.  This practice problem appears 
multi-factorial and current evidence must be reviewed to determine the best possible course of 
action.   
The Review 
Project Aim 
 The aim of this integrated review was to explore the state of evidence relative to safe 
chemotherapy administration in the outpatient setting as it applies to nursing knowledge and 
practice. 
Objectives 
 The objectives of this review were to (1) identify published accounts of safety 
interventions, surveys of knowledge, and risk factors for chemotherapy administering nurses; (2) 
conduct an appraisal of studies of safety interventions, surveys of knowledge, and risk factors; 
and (3) identify underlying themes in the studies that advance nursing knowledge of the 
application of safety techniques to oncology practice. 
Design 
 In order to explore the current state of knowledge relative to the safe handling of 
chemotherapy and to provide an appropriate integrated review of the literature, the five stages of 
Whittemore and Knafl (2005) were used.  These stages include clear identification and 
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articulation of the problem; retrieval of relevant literature through a systematic search; evaluation 
and analysis of data using defined criteria; and presentation of the findings (Whittemore & 
Knafl, 2005).  This review served as a framework for the organization of information throughout 
this paper.  Similarly to a recent integrative review by Stubbings, Chaboyer and McMurray 
(2012) the headings were renamed to reflect common elements in the research process for 
clarity.  In the initial review, the potential risk among oncology nurses who administer 
chemotherapy in outpatient settings was identified and relevant information was included.  This 
information includes variables of interest, concept, target population, and the clinical problem 
(Stubbings, Chaboyer, & McMurray).  In this case, the problem to be addressed by the 
integrative literature review has been identified as the utilization of chemotherapy safety 
techniques among oncology nurses.   
Search Methods 
 The literature search was conducted using the databases of PUBMED, PROQUEST and 
the Cumulative Index to Nursing and Allied Health (CINAHL).  The university medical librarian 
was also utilized as a resource during the review.  To gather information reflective of the current 
state of knowledge relative to the safe handling of chemotherapy, materials published earlier than 
1990 were excluded from the search.  This resulted in the inclusion of relevant data that 
represent the current state of science regarding this practice problem.   
Key words utilized to yield results included: “oncology nursing safety,” “risks of 
chemotherapy exposure,” “chemotherapy safe handling,” “chemotherapy safety,” “chemotherapy 
competency,” “hazardous drugs and nurse safety,” “antineoplastic safety,”  “chemotherapy 
protective equipment,” “occupational safety,” “hazardous drug exposure,” “medical monitoring 
of hazardous drug exposure,” “hazardous drug contamination,” “national chemotherapy safety 
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recommendations,” “national safety standards,” as well as “personal protective equipment 
guidelines.”   
Search Outcome 
 As in Whittmore and Knafl‟s review (2005), data evaluation was performed on all articles 
collected as a result of the aforementioned search methods.  Several articles were deemed 
irrelevant and removed following the evaluation.  Studies were dismissed if the variables of 
interest, concept, target population and clinical problem were not applicable to the purpose of the 
review (Stubbings, Chaboyer, & McMurray, 2012).  Literature was included if the articles were 
written in the English language and if they were qualitative, quantitative, mixed-method research 
or systematic reviews.  Topics related to chemotherapy safety, safe-handling guidelines, personal 
protective equipment utilization and nursing knowledge were included if methodology was clear 
and framework appropriate.   
Appraisal 
 Using the five phases for integrative review (Whittemore & Knafl, 2005), the retrieved 
articles were appraised.  Literature was included if findings contributed an understanding to the 
concept of chemotherapy safety among oncology nurses and if the methodology utilized was 
evidence based.  Although five of the articles were descriptive studies and involved self-
reporting surveys and telephone interviews, these were deemed appropriate due to their provision 
of extensive information that added to the existing body of knowledge regarding unnecessary 
exposure to chemotherapy.  For this same reason, two systematic reviews of literature were also 
included.  No randomized control trials were found in this review of evidence.   
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Data Abstraction and Synthesis 
 To demonstrate data abstraction and synthesis, Whittemore and Knafl‟s (2005) process 
was used to develop a synthesis table of evidence.  This table provided a summary for the 
purpose, design, sample, measurement tools and results of each retrieved study.  Arranged in this 
way, the research was easier to interpret and compare historically.  It also allowed the author to 
organize the data according to topic and to identify underlying themes.  The established themes 
were utilized to further analyze the studies in the discussion of results.   
Results 
 Of the twenty articles reviewed, all identified staff safety as an objective of their study.  
Five of the studies evaluated oncology staff exposure to hazardous drugs (Connor, Anderson, 
Sessink, Broadfield, & Power, 1999; Connor, et al., 2010; McDiarmid, Oliver, Roth, Rogers, & 
Escalante, 2010; Sessink, Boer, Scheefhals, Anzion, & Bos, 1992; Vandenbroucke & Robays, 
2001).  Four used the collection of surface wipe samples to measure environmental 
contamination (Connor, et al., 1999; Connor et al., 2010; Sessink, et al., 1992; Vandenbroucke & 
Robays, 2001), while three collected urine specimens from healthcare workers to assess 
personnel exposure (Connor, et al., 2010; Sessink, et al., 1992; Vandenbroucke & Robays, 2001) 
and one study used air samples (Sessink, et al., 1992).  Another study utilized blind fluorescent 
in situ hybridization (FISH) blood specimen analysis to determine the frequency of chromosomal 
abnormalities among healthcare workers (McDiarmid, et al., 2010) whereas a different study 
used gas chromatography and mass spectroscopy to determine if there is a difference in 
workplace contamination when comparing open and closed systems for the preparation of 
hazardous drugs (Vandenbroucke & Robays, 2001). 
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 Of these five publications (Connor, et al., 1999; Connor et al., 2010; McDiarmid, et al., 
2010; Sessink, et al., 1992; Vandenbroucke & Robays, 2001), countries of origin were the 
Netherlands (N = 1), Germany (N = 1), USA (N = 2), and multinational Canada and USA (N = 
1).  Four studies assessed a sample of both nursing and pharmacy staff, while one study limited 
its population to only pharmacy personnel.  Of the research that included nurses, samples sizes 
ranged from 25-121 healthcare workers.  An additional USA publication, surveyed 1,339 nurses 
in the state of Michigan (Friese, Ferris, Frasier, McCullagh, & Griggs, 2012).  This survey 
examined organizational structures and care processes that may be associated with hazardous 
drug exposure.   
 Four publications assessed safety, two of which sought to determine effective ways to 
prevent medication errors.  One of these two articles reviewed handwritten and electronic 
medication orders (Gahndi, et al., 2005), while the other simulated rates of errors related to 
administration (White, et al., 2010).  The remaining two studies sought to enhance the quality 
and safety of hazardous drug administration by using failure mode and effects analysis (Ashley, 
et al., 2011; Markert, Thierry, Kleber, Behrens, & Engelhardt, 2008).  Of these studies, the 
countries of origin were Canada (N = 1), United Kingdom (N = 1), Germany (N = 1) and the 
USA (N = 1).  Two of these utilized multidisciplinary teams, while the others strictly worked 
with a sample of oncology nurses.  Of the research done with nurses, the sample size ranged 
from 10-13 participants. 
    Three studies evaluated the use of personal protective equipment among oncology nurses 
(Martin & Larson, 2003; Polovich & Martin, 2011; Rizalar, Tural, & Altay, 2012).  Countries of 
origin were Turkey (N = 1) and the USA (N = 2).  One of these articles also assessed the 
knowledge of national safety guidelines among participants (Polovich & Martin, 2011).  All of 
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these researchers used various forms of questionnaires or mailed surveys to collect their data.  
The sample size ranged from 73-500 nurses.       
Four of the twenty studies, evaluated knowledge and explored nursing perception of 
exposure risks.  One study utilized focus groups and the application of content-analysis 
framework (Schwappach, Hochreutener, & Wernli, 2010), while another used a hazardous drug 
competency assessment with pre and post intervention surveys (Crannell, 2012).  A third article 
utilized a hazardous drug questionnaire (Fuller, Bain, & Sperrazza, 2007), whereas another 
publication used both mailed surveys and telephone interviews (Polovich & Clark, 2012).  Of 
these four studies, countries of origin were Switzerland (N = 1) and the USA (N = 3).  All of 
them assessed samples of oncology nurses and nurse managers from both inpatient and 
outpatient cancer centers.  Sample sizes ranged from 11-400 participants.   
To add to the existing knowledge base for this concept of chemotherapy safety, two 
systematic reviews were included in the synthesis of evidence.  One publication used a meta-
analysis of 14 studies to determine whether oncology personnel are at risk for reproductive 
complications and other adverse outcomes (Dranitsaris, et al., 2005).  A second review was 
conducted to develop a set of recommendations for the safe-handling of hazardous drugs in 
Canada (Green, et al., 2009).  Researchers surveyed practitioners as well to approve 
recommendations once developed by the panel of experts.  In addition to these reviews, a 
descriptive study that surveyed 44 cancer centers in the USA was also included.  This survey 
assessed the actual implementation status of national chemotherapy administration safety 
standards (Weingart, et al., 2012).     
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Defining Themes 
The general findings of this integrative review were consistent across disciplines and 
revealed four fundamental themes.  These include (1) the evaluation of hazardous drug exposure, 
(2) assessment of safety and the detection of medication errors, (3) the use of personal protective 
equipment and (4) nursing knowledge as it relates to the use of safe-handling precautions, 
national safety recommendations and the awareness of personal risk.   
Hazardous Drug Exposure 
Unnecessary exposure to chemotherapy can occur through a variety of methods, 
including inhalation, skin contact and workplace contamination (McDiarmid, et al., 2010).  This 
contamination occurs rapidly and is very difficult to eradicate once it exists (Vandenbroucke & 
Robays, 2001).  This finding implies that oncology nurses are at risk for exposure and the safety 
threat may extend to the general public as well.  In fact, Connor and colleagues (2010) found that 
despite the reported use of safety precautions, hazardous drug contamination is still present on 
surfaces in the workplace as well as in the urine of staff.  These results are consistent with 
previous findings that hazardous drug contamination of the workplace is widespread despite the 
use of recommended safety measures and workers are at risk for unintentional exposure (Connor, 
et al., 1999; McDiarmid et al., 2010; Rizalar, Tural, & Altay, 2012; Sessink, et al., 1992).   
 By means of blood specimen analysis, McDiarmid and colleagues (2010) have 
established that the frequency of handling hazardous drugs directly correlates to the number of 
chromosomal abnormalities found in staff.  Furthermore, nurses report a considerable amount of 
unintentional eye and skin contact when working with chemotherapy and identify that staffing 
and non-compliance to recognized practice standards may inhibit protection (Friese, et al., 2012).  
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Dranitsaris and colleagues (2005) have concluded that exposure to hazardous drugs is also 
associated with an increased risk of spontaneous abortions among female healthcare workers.  
Safety Assessment 
 A variety of safety assessments have been implemented to examine the quality and 
potential for errors in cancer treatment.  Gandhi and colleagues (2005) have determined that the 
potential for serious patient harm is present after reviewing handwritten and computer-entered 
medication orders.  This is consistent with other research that has identified a need for 
interventions to prevent errors in the chemotherapy process (Markert, et al., 2008; Ashley, et al., 
2011; White, et al., 2010).  These actions include the implementation of explicit checklists 
(White et al., 2010) and surveillance systems (Markert et al., 2008) to ensure medications are 
delivered without error to patients.  
Personal Protective Equipment 
Unfortunately, employers do not consistently have appropriate protective equipment 
available for staff use when handling chemotherapy (Polovich & Martin, 2011).  However, it has 
been implied that nurses are not fully compliant with safe-handling rules and regulations in terms 
of personal protective equipment use (Rizalar, Tural, & Altay, 2012) and major concerns still 
exist in regard to the management of chemotherapy spills (Martin & Larson, 2003).  
Additionally, Martin and Polovich (2003) have found that medical monitoring is not consistent 
with the Occupational Health and Safety Administration‟s guidelines.  Of 44 cancer centers 
surveyed, only 4 report the full implementation of hazardous drug safety standards as 
recommended by the Oncology Nursing Society and American Society of Clinical Oncology 
(Weingart et al., 2012).   
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Knowledge 
 Fuller, Bain, and Sperrazza concluded that there are significant misconceptions regarding 
the hazards of unintentional chemotherapy exposure (2007).  According to Polovich and Clark 
(2012), self-efficacy for the use of personal protective equipment is high as well as the perceived 
risk of harm among oncology nurses.  Despite these findings, the actual utilization of safe-
handling techniques is still reported to be quite low (Polovich & Clark, 2012).  When studied, 
nurses report considerable variations regarding barriers to the safe administration of 
chemotherapy (Schwappach, Hochreutener, & Wernli, 2010).  Additionally, while safe-handling 
policies are often present, many are outdated and few managers consistently monitor the use of 
hazardous drug precautions in the workplace (Polovich & Clark, 2012).  Furthermore, it has been 
found that nurses lack awareness of current safety guidelines (Polovich & Martin, 2011).  This 
literature review identifies gaps that suggest research is lacking in regard to the knowledge of 
oncology nurses and specific barriers to the safe-handling of chemotherapy (Martin & Larson, 
2013).   
Summary 
 This literature review suggests that hazardous drug exposure and workplace 
contamination is occurring despite the reported use of safe-handling precautions.  This brings 
attention to national safety concerns and discrepancies within current oncology practices.  
Evidence further supports the assumption that a knowledge deficit may be present among 
oncology nurses in regard to the safe administration of chemotherapeutic agents.  Conclusions 
from this review suggest there are gaps in practice relative to chemotherapy safety.  The 
reviewed literature has been categorized into four common themes that include: the evaluation of 
hazardous drug exposure; the assessment of safety; the use of personal protective equipment; and 
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the measurement of knowledge.  This literature review based on Whittemore and Knafl‟s (2005) 
framework has facilitated the establishment of a scientific foundation for the selected practice 
problem and serves as an important aid in the exploration of oncology nursing practice and the 
identification of potential knowledge deficits. 
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CHAPTER 3 
 
CONCEPTUAL FRAMEWORK 
 
 
 The purpose of this chapter is to explore the conceptual basis for the development, 
implementation, and evaluation of this practice inquiry.  To examine healthcare services and 
assess quality of care, Donabedian‟s theoretical framework was employed to drive the 
intervention.  Donabedian‟s model initially focused on the evaluation of patient care 
(Donabedian, 2005) but his later work provided a more comprehensive examination of 
healthcare quality (1990) and even the application of science and technology (1993).  The chief 
elements of his model include the assessment of structures, processes and outcomes.  Exploring 
these components of Donabedian‟s framework is imperative to exploring oncology nurse 
practices associated with the safe-handling of chemotherapeutic agents. 
 According to Donabedian, the concept of structure is associated with the organizational 
properties of the physical healthcare setting.  This involves elements that include workplace 
supplies, human resources, management and the mission and values of the organization.  As it 
relates to nursing and chemotherapy safety, Donabedian‟s structure highlights features that are 
linked to the outpatient oncology clinic such as leadership, skill and knowledge levels of 
personnel, existence of workplace distractions, staffing ratios and patient population.  In this 
case, the structure also involves the presence and availability of material supplies related to the 
safe administration of chemotherapy including personal protective equipment, hazardous waste 
containers and spill kits.   
 Donabedian‟s concept of process is associated with the actual service being provided in 
the healthcare setting or the main variable of interest.  This represents the intervention that has an 
impact on outcomes.  In this case, it is the physical handling of chemotherapeutic agents by 
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outpatient oncology nurses.  Process as defined by Donabedian, involves various policies and 
procedures related to nursing safety when performing this task.  It incorporates the 
implementation of evidence-based practice guidelines and the enforcement of any standards or 
recommendations aimed at increasing nurse safety when administering chemotherapy and the 
management of this issue.  If chief structural components do not support the aims of the process 
or are lacking altogether, outcomes will be adversely affected.  The application of Donabedian‟s 
model in this case suggests the main objective of quality improvement is to perfect the concepts 
of structure and process in order to mitigate the risk of adverse effects related to the mishandling 
of chemotherapeutic agents.      
 Conceptually, outcome is the end product of both the structure and process.  Therefore, a 
favorable outcome would be associated with supporting structures and processes, while adverse 
outcomes may be linked to poor components or the failure to be compliant.  While evaluating 
outcomes, one must always account for external influencing variables including those that may 
arise from society (Donabedian, Wheeler & Wyszewianski, 1982; Donabedian, 1996).  That is, 
contributing factors outside the intervention that may manipulate outcomes, like the availability 
of material resources, financial affairs, conflicts of interest and the culture of safety in the 
outpatient oncology clinic.  The assessment of outcomes is crucial to prevent the undesirable 
effects associated with the mishandling of chemotherapy by nurses.  These events may include 
workplace contamination and the unnecessary chemotherapy exposure of staff and the general 
public with accompanying biological consequences.   
Donabedian‟s model provides a methodical basis for the examination of the structure, 
process and outcomes that are fundamental to the provision of safe, quality cancer care and the 
establishing of opportunities to mitigate superfluous risks related to the mishandling of 
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chemotherapy in the outpatient environment.  Donabedian‟s model facilitated the driving of the 
intervention of this practice inquiry, however, the use of multiple perspectives are important to 
guide the process of knowledge translation (Estabrooks, Thompson, Lovely & Hofmeyer, 2006) 
so the PARiHS (Promoting Action on Research Implementation in Health Services) framework 
was also utilized.   
The PARiHS framework was employed to drive the implementation phase of this practice 
inquiry.  In order to successfully implement evidence to practice, knowledge gaps must first be 
identified (Kitson & Straus, 2010).  Within this framework, successful implementation occurs as 
a function of evidence, the context of the evidence, and the facilitation of the process (Kitson, 
Rycroft-Malone, Harvey, McCormack, Seers & Titchen, 2008).  This model was originally 
formulated as a result of practice development, quality improvement, and research work, 
although it has been refined over time to assess validity (Melnyk & Fineout-Overholt, 2011).  
The main components of this model include evidence, context and facilitation.   
This model involves evidence retrieved from research, clinical experience, patient and 
caregiver experience, and local context (Melnyk & Fineout-Overholt, 2011).  Relevant evidence 
for the purpose of this practice inquiry may involve clinical research regarding hazards of 
exposure to chemotherapeutic agents, safety assessments of oncology nursing knowledge and 
skill sets, and recognized chemotherapy handling guidelines and recommendations.  Important 
local information to obtain includes workplace policies and procedures of the outpatient 
oncology clinic.   
The contextual element refers to the specific setting in which the proposed intervention is 
to be implemented (Melnyk & Fineout-Overholt, 2011).  This environment is an outpatient 
oncology clinic in a metropolitan area with multiple regional clinics.  The culture of safety, 
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characteristics of leadership and methods of workplace evaluation in this site will affect the 
context.  Settings that have “transformational leaders, features of learning organizations, and 
appropriate monitoring, evaluative, and feedback mechanisms” are more effective in providing 
the context for the successful implementation of evidence than others without these key 
attributes (Kitson et al., 2008). 
Facilitation is the process that enables the transition from evidence into practice (Melnyk 
& Fineout-Overholt, 2011). Facilitators often depend on the institution of interest as well as the 
individuals and context involved.  This phase of the model is conducted by individuals with 
appropriate skills and knowledge to assist the application of evidence into practice.  It is 
important for these facilitators to be flexible so they are capable of adjusting their role as needed 
during the various stages of implementation.  These individuals also evaluate the elements of 
evidence and context to assess the current state of the organization and its readiness for change 
(Kitsen et al., 2008).  
The PARiHS framework identifies elements that may warrant attention throughout the 
implementation phase and acts as a reliable instrument during and at the conclusion of the 
practice project to evaluate progress and outcomes.  This framework provides a conceptual basis 
for which the evidence, contextual setting, and potential facilitators can be reviewed in regard to 
the safe handling practices of outpatient oncology nurses to guide the successful translation of 
evidence.  
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CHAPTER 4 
 
METHODS 
 
 
The purpose of this chapter is to delineate the project plan, identify methodology and 
timeline, as well as explore potential outcomes.  Additionally, an in-depth examination of the 
target population, instrument of measurement, and procedures of this practice dissertation will 
ensue.  Throughout the development of this practice project, communication with key 
stakeholders has occurred to facilitate the identification of potential barriers and to enhance the 
acceptance of the intervention.   
Design 
 In order to collect data for this practice project, an established survey instrument was 
selected to gather information directly from respondents.  The survey method is a common and 
effective approach to gathering data relative to experience, perceptions, attitudes and behaviors.   
Sample 
Participants for this intervention included all registered nurses who administer 
chemotherapy for a large cancer and hematology center at one of its multiple ambulatory clinics.  
The inclusion criterion for participation included current full and or part time employment at the 
organization, licensure as a registered nurse, working in a position that includes chemotherapy 
preparation, administration, disposal, and or potential exposure to contaminated patient 
excrements via the emptying of bedpans, urinals or emesis basins.  Registered nurses who had 
not yet completed their orientation at the time of project implementation and were practicing 
under the instruction of a mentor were excluded from participating in the study. 
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Terminology 
For the purposes of this practice project, administration of chemotherapy was defined as 
the dispensing of medication to patients via intravenous, intramuscular, subcutaneous, or enteral 
routes.  Disposal was distinguished as the discarding of all paraphernalia associated with the 
preparation or administration of chemotherapy.  It should be noted that pharmacy personnel 
prepare all chemotherapy at the organization of interest.  While the implemented survey 
collected data regarding the preparation of chemotherapy it was not applicable to the oncology 
nurses that chose to participate.     
Organizational Assessment 
 The location for this project was a large, ambulatory cancer and hematology center in a 
Midwestern city.  This organization is made up of six satellite clinics that provide outpatient 
oncology treatment for adults in both rural and urban settings.  The location was chosen based on 
its convenient location and its association with the topic of interest.  Treatment services are 
provided for a variety of oncology and hematology diseases by a number of specialists and sub-
specialists.  The team consists of 21 physicians, 9 nurse practitioners, 10 physician assistants and 
68 registered nurses.  Within the organization there are also a number of medical assistants, 
social workers, financial coordinators, lab technicians, pharmacists, dieticians and front office 
staff.  Members of this group work collaboratively to meet the demanding needs of their patients.  
In addition to this, the organization has partnered with multiple local hospitals and healthcare 
providers to facilitate better transitions of care. 
Procedures 
A packet that included a color-coded survey as well as a postage-paid, return envelope 
was mailed to the home address of all staffed registered nurses (N = 68).  The survey was color-
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coded based on the participants‟ primary site worked allowing for further analysis of responses 
and comparison among clinics.  Participation was entirely voluntary and involved no out-of-
pocket expenses.   The surveyed nurses were informed that they could opt out at any time 
without penalty.   
Participants were instructed to return the survey to the university address of the 
dissertation chairperson within two weeks of its receipt.  No personal identifying data were 
collected and data were only reported in aggregates.  It should also be noted that demographic 
items (i.e. gender or ethnicity) that allowed for the indirect identification of a participant were 
removed from the survey prior to its distribution. 
In employing this self-administered, mailed survey, the sample was not restricted in size 
or to a specific geographic location.  This also allowed for the completion of the survey in one‟s 
own home where respondents may provide more accurate and comprehensive information on a 
potentially sensitive topic.  Mailed surveys are also reportedly easier to implement than other 
means of gaining information and require fewer personnel to put into action (Bourque & Fielder, 
2003).  Applying the survey in this way allowed for consistent stimuli among participants and 
the potential to study a widely represented sample (2003).   
According to Bourque and Fielder, a single mailing questionnaire will likely produce a 
response rate no greater than 20% of the sample (2003).  However, mailed surveys produce 
better responses than those conducted online, although they are still lower than telephone and in-
person interviews.  To increase the response rate for this study, initial contact was made with the 
participants to thank them for their participation and to make them aware that a parcel was to be 
mailed to them as outlined earlier in this chapter.   
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For the purposes of this practice inquiry a response rate of 30% was desired.  After the 
initial mailing a response rate of 29% was obtained.  At this time the Dillman method was 
employed to increase the return rate of the surveys (Hoddinott & Bass, 1986).  An additional 
packet was again sent to all participants to maintain privacy and confidentiality.  This parcel 
contained an additional copy of the color-coded survey and a letter to follow up with all 
participants to address questions or concerns, encourage them to submit their surveys if they had 
not already done so, and thank them again for their participation.  After the second mailing the 
overall response rate increased to 53% and was deemed acceptable for the purposes of this 
project.  Demographic data was monitored closely to ensure no duplicate surveys had been 
submitted. 
Implementation 
 This project was implemented using an established survey.  Average completion time for 
the survey was approximately 20-30 minutes.  This tool was used to evaluate the knowledge of 
safe chemotherapy administration among outpatient oncology nurses employed by a large, multi-
site cancer and hematology center.  In collaboration with this organization‟s administrative staff, 
a list of the number of nurses working at each site was obtained.  To maintain privacy and 
confidentiality, all correspondence and communication from the project manager was sent via 
the organization‟s human resources staff.  Approximately one week prior to mailing out the 
surveys, an information letter was sent to nursing staff to inform them that they would soon 
receive a parcel by mail and to explain the goals of the project.  At that time, the project 
manager‟s contact information was provided so that participants could contact the manager 
directly with any questions or concerns. 
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Facilitators of this practice project included the active participation of administrative staff 
who were willing to allow the use of their organization as a project site.  Permission was granted 
to utilize a user-friendly, established survey that has been previously deemed both reliable and 
valid.  With permission from Dr. McCullagh to adapt her Farmers Social Norms and Social 
Modeling scales, Dr. Polovich developed the aforementioned survey to further explore 
chemotherapy safety among nurses (Polovich & Clark, 2012).  Permission was granted by both 
of these experts to employ the survey in its entirety for the purposes of this project (M. 
McCullagh, personal communication, April 4, 2014, M. Polovich, personal communication, 
March 26, 2014).   
 The survey utilized in this intervention was developed in 2003 and consisted of twenty 
questions on chemotherapy handling.  The tool was then revised in 2011 and again in 2012 to 
remain consistent with changing guidelines.  The survey as implemented for this project included 
questions to represent the following scales: exposure knowledge, self-efficacy for using PPE, 
barriers to using PPE, perceived risk of chemotherapy exposure, workplace safety climate, 
conflict of interest, interpersonal norms and interpersonal modeling.  The most recent revision 
was utilized for the purpose of this study with reliability and validity previously confirmed via 
testing by its author, Dr. Martha Polovich (M. Polovich, personal communication, April 12, 
2014).   
 Content validity for the Chemotherapy Handling Questionnaire was assessed using a 
universal agreement method whereby three nurses with experience in chemotherapy 
administration and occupational safety described common practices related to chemotherapy 
handling (M. Polovich, personal communication, April 12, 2014).  The evaluation scale 
ultimately included options of four responses dichotomized from “relevant” to “not relevant.”  
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Several items were modified after the first appraisal due to low content validity index.  During 
the second evaluation all items had a content validity index of 1.0 which is appropriate when less 
than five experts assess an instrument.  For reliability, Dr. Polovich constructed a pilot study 
using a non-random sample of 20 oncology nurses who completed the survey on two separate 
occasions, two weeks apart.  Cronbach‟s alpha was calculated for each scale represented in the 
survey and ranged from .70-.925 (M. Polovich, personal communication, April 12, 2014).  In 
social science research situations, a value of .70 or higher is considered satisfactory or good 
(Tavakol & Dennick, 2011).   
Statistical values reported for the Chemotherapy Handling Questionnaire include: sample 
size, scale range, observed range, mean and standard deviation for each of the scales previously 
mentioned.  Additionally, the mean and standard deviation for nurses‟ use of safety precautions 
when handling chemotherapy were also noted.  This data was not recorded for each clinic due to 
the low response rate of some locations.  To maintain the privacy and confidentiality of the 
participants that did respond, data was only analyzed for the entire sample. 
To assure accuracy, double data entry was performed and data were compared.  Errors 
were corrected prior to analysis.  Spearman‟s rank correlation coefficient was calculated to 
evaluate relationships between participant demographics, survey variables and the overall use of 
chemotherapy safe-handling precautions.  A significance value of 0.05 was used for all data 
analysis.   
After analysis, the results of the survey were communicated to key stakeholders so that 
an action plan could be collaboratively discussed to improve nursing safety associated with the 
safe administration of chemotherapy.  Potential outcomes include educational interventions 
resembling mandatory in-services, competency testing and/or the development of a 
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chemotherapy safety council.  Dependent upon the goals of the organization, outcomes may 
consist of workplace alterations (i.e. minimizing distractions) and/or modifications to 
chemotherapy safe-handling policies.  Program and process evaluation occurred throughout the 
project to establish a foundation for future efforts and the results of the survey have encouraged 
the course of action. 
The timeline for the project was developed to allow maximum participation from 
respondents.  This involved four months with ample time to distribute the survey in two mailings 
and allow the return of complete responses.  Issues commonly associated with surveys were 
identified and a second mailing was required to obtain an adequate response rate.  Program and 
process evaluation as well as the ongoing development of recommendations for an action plan 
occurred throughout the implementation of the practice project.      
Project barriers to implementation were recognized and included the expenses associated 
with mailing surveys, although these costs are actually 50% less than those associated with in-
person or telephone interviews (Bourque & Fielder, 2003).  Barriers may have also included a 
fear of being associated with the results, especially since the information was obtained with the 
assistance of the participants‟ employer.  Another disadvantage of a mailed survey is that it is 
self-administered and an obvious lack of control exists over who responds.  Therefore, the survey 
must stand alone.  Mailed surveys are reportedly notorious for having low response rates as well, 
especially with no offered incentives.   
Evaluation 
In summary, the Chemotherapy Handling Questionnaire proved to be a usable method to 
collect data on nursing practice and establish their behavior and attitudes regarding safe 
chemotherapy administration in an outpatient, Midwest oncology clinic.  Indicators that 
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determine the success of the project included a good response rate and the return of several 
complete surveys.  The survey facilitated the capturing of a large portion of the sample 
population (53%) when the desired response rate was 30%.  The level of responses in this 
practice project far exceeded expectations suggesting the successful utilization of the survey to 
assess the nursing perceptions of chemotherapy administration and PPE use in this practice 
setting.     
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CHAPTER 5 
 
RESULTS 
 
 
 The purpose of this chapter is to describe the results obtained from the Chemotherapy 
Handling Questionnaire developed by Dr. Martha Polovich (2012) and distributed to registered 
nurses employed by a multi-centered, outpatient chemotherapy clinic.  This survey assessed 
personal demographics of respondents related to the practice of nursing as well as individual 
practices and behaviors linked to the administration of chemotherapeutic agents in the outpatient 
setting.  The organization of interest has multiple satellite clinics that were contacted to collect 
data for the purposes of this practice inquiry. 
Responses 
 A total of 40 completed surveys were returned from an eligible population of 68 
registered nurses employed by one of six satellite clinics.  The initial mailing yielded 20 
completed surveys with a response rate of 29%.  Three weeks later, a second survey was mailed 
and an additional 16 surveys were returned for a total response rate of 53%.  Four completed 
surveys were returned after the established deadline and were not included in final tabulations.     
Among respondents, 15 of the returned surveys were from Clinic A (51.2% of those surveyed 
from this location); 8 surveys from Clinic B (72.7% of those surveyed); 6 from Clinic C (66.7% 
of those surveyed); 5 from Clinic D (45.5% of those surveyed); 1 from Clinic E (20% of those 
surveyed) and 1 from Clinic F (33.3%).  All participants reported that their position required they 
handle chemotherapy via administration, chemotherapy disposal or the handling of potentially 
contaminated excreta.  
For clarity, survey responses were categorized into four main topics:  descriptive 
characteristics of the sample; results of the survey by scales (self-efficacy for using personal 
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protective equipment, perceived barriers, perceived risk, interpersonal modeling, interpersonal 
norms, conflict of interest and workplace safety climate); frequency of use of safe-handling 
precautions during select activities required during chemotherapy administration, and significant 
relationships established among variables.   
Missing Data 
To address missing data, a formula for single-value, personal mean imputation was 
utilized.  A missing data method was necessary to support the accuracy and completeness of 
individual responses that were missing at random (Osborne, 2013).  Since empirical evidence 
verifying the randomness of missing data may be difficult to obtain, researchers often have to 
explore potential causes to justify whether the data is indeed random (Pigott, 2001).  Possible 
explanations for individual missing data in this study may include:  less involved staff; little 
interest in the topic of chemotherapy safe-handling; confusing survey items; controversial 
questions regarding one‟s place of employment; fear of identification; individual survey 
questions did not apply to the respondent; and/or respondents wished to remain neutral when it 
was not an option. 
 According to Osborne (2013), if 20% or more of a participant‟s response is missing, 
substituting scores for such a large portion of their individual data can artificially reduce the 
overall variance of the variable within the study.   Thus, if 20% or greater of a participant‟s 
response for a given scale was missing, a mean was not imputed and the data were not utilized 
for scoring purposes for that particular variable.  However, if at least 80% of the scale responses 
were available, the participants‟ personal scores were averaged to impute a mean that replaced 
the missing data.   
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 Within the study, the survey scales that assessed the participants‟ perception of risk, 
interpersonal modeling, interpersonal norms, and conflict of interest had no missing data.  Two 
participants missed questions on the chemotherapy knowledge scale that were averaged and 
imputed.  Two participants missed questions regarding their self-efficacy for PPE use, while one 
nurse did not complete the scale in its entirety.  Thus, the latter data was not utilized for scoring 
purposes and only two personal averages were imputed for the self-efficacy scale.  Three 
participants‟ responses were replaced for the perceived barriers scale and one participant‟s 
response was imputed for the scale that measured the climate of workplace safety for the 
organization of interest.     
Characteristics of the Sample 
  
Overall, respondents reported considerable experience as registered nurses as well as 
experience in oncology and the administration of chemotherapy.  Most participants were middle-
Table 1   
Sample Characteristics 
  
M 
 
SD 
Age (years) 44.0 14.0 
Experience (years) 
     Nursing 
     Oncology 
 
19.0 
14.0 
 
13.4 
10.1 
  
M 
 
Mdn                         
Treatment Volume 
Patients per nurse per day 
10.0 10.0 
  
%   
 
N  
Education 
     Diploma 
     Associate‟s degree 
     Bachelor‟s degree 
     Master‟s degree 
 
8.3 
19.4 
63.9 
8.3 
 
3 
7 
23 
3 
Note.  Mdn – median, SD – standard deviation, M - mean, % - percent 
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aged (range = 25-68, SD = 14) with an average age of 44 years.  Reponses were received from all 
six of the organization‟s clinics in varying geographic locations within the Midwestern state.  
The majority of nurses had earned the designation of Oncology Certified Nurse (OCN) (80.6%) 
and reported that they were a member of the Oncology Nursing Society (ONS) (69.4%).  Of the 
36 respondents, 33 were also ONS certified to administer chemotherapy and biotherapy (91.7%).  
Most staff typically worked 10 hour days and the average case load managed per day for 
chemotherapy treatment was 10.0 (range = 5-12, SD = 1.84).  Table 1 summarizes the descriptive 
statistics for characteristics of the sample population. 
Descriptive Statistics for Survey Scales 
 Table 2 displays the descriptive statistics for each of the scales present in the 
Chemotherapy Handling Questionnaire that were utilized for the purposes of this project.  In 
regard to chemotherapy exposure knowledge, the item most often answered incorrectly (22 out 
of 36 nurses, 61.1%) was “A surgical mask provides protection from chemotherapy aerosols” 
(correct answer:  false).   “Chemotherapy can more easily enter the body through damaged skin” 
(correct answer:  true) was answered incorrectly by seven nurses (19.4%) and “Alcohol hand 
sanitizer is as effective as soap and water in removing chemotherapy residue” (correct answer:  
false) was answered incorrectly by eight participants (22.2%).  In contrast, seven participants 
answered all items correctly (19.4%), while 13 answered only one question wrong (36.1%), and 
10 nurses answered two items incorrectly (27.8%).  In general, nurses were knowledgeable about 
chemotherapy exposure as they averaged 10 correct of the 12 items on this portion of the survey 
earning higher scores, indicating higher levels of knowledge.   
 Nurses reported moderate levels of both self-efficacy (M = 15.6, possible range = 7-28) 
for using personal protective equipment (PPE) and perceived barriers (M = 25.2, possible range 
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= 13-52) to PPE use for safe chemotherapy administration.  On these portions of the survey, 
higher scores suggest higher levels of both self-efficacy and perceived barriers to PPE use.  In 
regard to perceived barriers, items with the highest ratings were related to PPE being 
unavailable, the lack of a policy that requires PPE use, nurses feeling too hot when wearing PPE, 
and coworkers observed not using personal protective equipment.  Participants identified the 
difficulty in obtaining chemotherapy-designated PPE as an additional barrier to their use of 
safety precautions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 
Descriptive Statistics for Survey Scales 
Variable M SD Observed 
Range 
Possible 
Range 
Chemotherapy 
exposure 
knowledge 
(N = 36) 
10.4 1.4 5 - 12 0 - 12 
Self-efficacy 
for using PPE 
(N = 35) 
15.6 4.0 8 - 23 7 - 28 
Perceived 
barriers 
(N = 35) 
25.2 8.3 13 - 41 13 - 52 
Perceived risk 
(N = 36) 
1.9 0.6 1 - 4 1 - 4 
Interpersonal 
modeling 
(N = 35) 
2.8 0.6 0 - 3 0 - 3 
Interpersonal 
norms 
(N = 35) 
1.7 0.4 0 - 2 0 - 2 
Conflict of 
interest 
(N = 36) 
10.7 3.5 6 - 17 6 - 24 
Workplace 
safety climate 
(N = 36) 
70.4 15.6 32 - 102 21 - 105 
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In regard to perceived risks, Table 2 displays a lower average suggesting this sample of 
nurses perceives a low risk of harm from chemotherapy exposure.  Nurses also reported a low 
conflict of interest between the need to protect themselves and at the same time care for patients 
while handling chemotherapy.  This is evidenced by lower scores on this section of the survey 
suggesting lower levels of conflict of interest.  Conflict of interest items with the highest scores 
were associated with the inability to meet patient needs when using safe-handling precautions 
and that patient care and associated interruptions interfere with the ability to comply with the use 
of precautions.  In addition to these items, participants often perceived that wearing PPE made 
their patients feel uncomfortable.  
 High average scores for the interpersonal scales (see Table 2) suggest that nurses 
perceived that in general coworkers valued and used safety precautions when handling 
chemotherapy.  However, nurses reported only moderate scores for the scale of workplace safety 
climate and the variability among answers was quite high (SD = 15.6), suggesting opinions on 
the climate of safety within the workplace vary considerably.  For this scale, higher scores 
indicate perceptions of a better safety climate, therefore the items with the lowest scores were 
examined to assess the participant‟s concerns with the organization‟s climate of safety.  The 
items with the lowest scores were associated with limited accessibility to chemotherapy gloves in 
the work area; conflict within the work area; minimal support from members of the work area; a 
lack of open communication between supervisors and staff; and some nurses reporting they are 
not expected to comply with safe-handling policies and procedures within the work area. 
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Frequency of Use of Safe-Handling Precautions 
 Table 3 describes the frequency of precaution usage reported by nurses when handling 
chemotherapy during various activities including administration, disposal, and the handling of 
excreta.  No participants reported that they prepare chemotherapy (N = 0) so these data were 
omitted from the table.  The reported use of chemotherapy-designated gloves was high and 
reported gown use was low for all of the handling activities.  Double gloving, the use of eye 
protection and respirators were reported as rarely used by participants from this organization.  
Overall reported precaution use was highest for the handling of contaminated excreta and 
disposal of chemotherapy (M = 1.2, SD = 0.8, M = 1.2, SD = 0.7) and slightly lower for the 
administration of chemotherapy (M = 1.1, SD = 0.8).   
 
Table 3  
Nurses’ Precaution Use when Handling Chemotherapy 
 Administration 
(N = 33) 
Disposal 
(N = 34) 
Handling Excreta 
(N = 28) 
 M SD M SD M SD 
Gloves  
(chemotherapy-
designated) 
 
3.7 
 
2.0 
 
4.1 
 
1.8 
 
4.1 
 
1.8 
 
Double Gloves 
 
0.5 
 
1.3 
 
0.4 
 
1.1 
 
0.2 
 
0.8 
 
Gowns 
 
0.9 
 
1.9 
 
1.4 
 
2.2 
 
1.8 
 
2.3 
 
Eye Protection 
 
0.3 
 
0.9 
 
0.1 
 
0.2 
 
0.2 
 
1.0 
 
Respirator 
 
0.2 
 
0.7 
 
0.0 
 
0.2 
 
0.2 
 
1.0 
 
Overall 
Precaution Use 
 
 
1.1 
 
 
0.8 
 
 
1.2 
 
 
0.7 
 
 
1.2 
 
 
0.8 
Note.  Response options were 0 = never, 1 = 1%-25% of the time, 2 = 26%-50%, 3 = 
51%-75%, 4 = 76%-99%, 5 = always.   
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Relationships among Variables 
Spearman‟s rank correlation coefficients (  ) were calculated to evaluate relationships 
between scale variables, nurse demographics and the overall use of safe-handling precautions  
 
Table 4 
Spearman’s Correlation Coefficients (  ) among Scale Variables, Nurse Demographics and 
Use of Safe-Handling Precautions  
 Age 
(N = 35) 
Nursing 
Experience 
(years) 
(N = 35) 
Oncology 
Experience 
(years) 
(N = 35) 
Education 
(N = 36) 
Treatment 
Volume  
(per nurse 
per day) 
(N = 36) 
Chemotherapy 
exposure 
knowledge  
(N = 36) 
0.29 (.09)  
 
0.23 (.12) 0.15 (.40) 0.0 (1.0) 0.14 (.41) 
Self-efficacy 
for using PPE 
(N = 35) 
-0.22 (.21) -0.18 (.29) -0.14 (.42) -0.08 (.64) -0.44**  
Perceived 
barriers  
(N = 35) 
-0.12 (.28) -0.12 (.49) -0.20 (.25) -0.14 (.41) 0.32 (.06) 
Perceived risk 
(N = 36) 
0.04 (.82)  0.12 (.48) 0.06 (.75) -0.02 (.89) -0.08 (.64) 
Interpersonal 
modeling  
(N = 35) 
0.08 (.66) -0.02 (.92) -0.02 (.91) 0.12 (.50) -0.08 (.65) 
Interpersonal 
norms 
(N = 35) 
0.10 (.57)  
 
-0.02 (.92) 0.01 (.93) 0.07 (.68) -0.28 (.10) 
Conflict of 
interest  
(N = 36) 
0.10 (.59) 0.06 (.74) 0.06 (.73) -0.29 (.09) 0.37* (.03) 
Workplace 
safety climate 
(N = 36) 
0.20 (.25) 0.14 (.44) 0.14 (.43) -0.05 (.76) -0.21 (.21) 
Overall 
precaution use 
(N = 33) 
0.14 (.43) -0.24 (.16) -0.36* (.04) 0.17 (.34) 0.11 (.53) 
Note.  For each calculation the lesser N was used as the testing required matched pairs.  
Corresponding p values are denoted in parentheses after each coefficient.   
(* p < 0.05; ** p < 0.01) 
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(see Tables 4 and 5).  Statistically significant correlations of varying strengths (p < 0.05 and p <  
0.01) were found between several of the sample traits and scale variables.  An inverse 
relationship was found between years of oncology experience and the overall use of safety 
precautions.  That is, the more years of oncology experience nurses had, the less likely they were 
to use personal protective equipment (               ).  Higher treatment volume was 
affiliated with lower levels of self-efficacy for PPE use (               ) and an increase in 
perceived conflicts of interest between PPE use and the provision of patient care (          
    ).  Overall precaution use was not associated with age, education, treatment volume or years 
of nursing experience.         
 The potential relationships among scale variables and the overall use of safety 
precautions were also examined using Spearman‟s rank correlation coefficient.  Chemotherapy 
exposure knowledge and perception of exposure risks were not significantly associated with any 
other variable.  Higher perceived barriers and conflicts of interest were related to lower levels of 
self-efficacy for the use of PPE (        ,         ) and lower safety climate scores 
(        ,         ).  Higher levels of self-efficacy were associated with perceptions of a 
better workplace safety climate (   = 0.80, p < 0.01).     
 Higher conflict of interest scores were associated with increased perceived barriers to 
PPE use and more negative interpersonal influences (       ,                  ).  
Positive interpersonal norms for PPE were associated with a better climate of safety (   
           ) as well as more positive interpersonal modeling (              ).  Of the 
scale variables included in the survey, only interpersonal modeling was associated with total 
precaution use.  Positive interpersonal modeling was related to an increased overall use of 
chemotherapy safety precautions (              ).   
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 Seven participants provided answers to the final open-ended survey question that 
solicited ideas for chemotherapy safety practice improvement.  Three responses described access 
issues to appropriate PPE, specifically disposable gowns; two reported concerns related to 
environmental safety and the cleaning of workstations and equipment; and two identified a need 
for further education and training. 
 Findings from the Chemotherapy Handling Questionnaire point to important 
discrepancies and gaps in practice related to nursing perceptions of chemotherapy safety and 
PPE use.  Although nurses reported higher levels of exposure knowledge and moderate levels of 
self-efficacy for using personal protective equipment, they perceived low risks of harm from 
chemotherapy exposure and the overall reported use of precautions was low.  Results also 
suggest moderate levels of perceived barriers and participants only scored their organization 
moderately (with wide variation in responses) for workplace safety.  In summary, the 
Chemotherapy Handling Questionnaire revealed multiple opportunities for quality improvement 
and mitigation of safety hazards in the outpatient workplace.  The survey proved to be an integral 
part of the environmental assessment and has the potential to contribute to future work in order 
to improve the quality and safety of chemotherapy administration. 
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Table 5 
Spearman’s Correlation Coefficients (  ) among Scale Variables and Nurses’ Use of Safe-Handling Precautions 
 Chemotherapy 
exposure 
knowledge  
(N = 36) 
Self-
efficacy for 
using PPE  
Perceived 
barriers 
Perceived 
risk 
Conflict of 
interest 
Interpersonal 
norms 
Interpersonal 
modeling 
Workplace 
safety 
climate 
Self-efficacy 
for using PPE 
(N = 35) 
0.09 (.63)        
Perceived 
barriers  
(N = 35) 
0.09 (.59) -0.66**        
Perceived risk 
(N = 36) 
0.03 (.86) -0.01 (.94) 0.14 (.42)      
Conflict of 
interest  
(N = 36) 
0.27 (.11) -0.46** 0.70** 0.12 (.49)     
Interpersonal 
norms  
(N = 35) 
0.11 (.52) 0.11 (.53) 0.17 (.33)  
 
-0.06 (.75) -0.42**     
Interpersonal 
modeling  
(N = 35) 
0.14 (.43) 0.21 (.23) 0.11 (.53)  -0.03 (.87) -0.39* (.02) 0.64**   
Workplace 
safety climate 
(N = 36) 
0.11 (.52) 0.80**  
 
-0.76** 
 
-0.02 (.93) -0.44**  0.71** 
 
0.46**   
Overall 
precaution use 
(N = 33) 
0.09 (.61) -0.06 (.75) -0.12 (.49) 0.04 (.84) 0.04 (.83) 0.15 (.42) 0.41* (.02) -0.20 (.26) 
Note.  For each calculation the lesser N was used as the testing required matched pairs.  Corresponding p values are denoted in 
parentheses after each coefficient.  (* p < 0.05; ** p < 0.01) 
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CHAPTER 6 
 
DISCUSSION 
 The purpose of this chapter is to provide a discussion of results obtained from the 
implementation of the Chemotherapy Handling Questionnaire (Polovich, 2012) in a large, 
outpatient oncology practice with multiple satellite clinics.  Additionally, this chapter will 
highlight the role of the DNP-prepared clinician as it relates to the application of this practice 
improvement process. 
Application of Findings to Existing Evidence 
 Although the toxicity of chemotherapeutic agents is well documented, the nurses that 
participated in this survey reported a low overall use of safety precautions when administering 
chemotherapy.  These findings are consistent with previous literature as they reinforce that 
recommended practices are not always followed, despite the availability of safety guidelines 
developed by professional practice organizations (Boiano, Steege & Sweeney, 2014; Martin & 
Larson, 2003; Polovich & Clark, 2012; Polovich & Eisenburg, 2009).     
 Consistent with other findings in the literature, the use of double gloving, eye protection 
and respirators were rarely used by respondents of this oncology group.  These findings are 
similar to those of a recent National Institute for Occupational Safety and Health (NIOSH) study 
where 80% of nurses reported they do not always use the recommended two pairs of gloves 
when handling chemotherapy (Marcus, 2014).  In the 2014 NIOSH study, nurses cited the use of 
personal protective equipment (PPE) was not required as part of their protocol or always 
provided by their employer (2014).  This is also consistent with the findings of this dissertation 
inquiry as participants reported barriers to using safety precautions that included unavailability of 
PPE; difficulty in obtaining chemotherapy-designated PPE; the lack of a policy that required its 
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use; nurses feeling physically uncomfortable (too hot) when wearing PPE; and coworkers around 
them not using protective equipment.   
 Although the samples are unequal, the examination of Polovich‟s previous research is 
important for this inquiry as the same instrument of measurement was utilized and some 
comparisons can be made.  Polovich implemented this tool in a national sample consisting of 
Oncology Nursing Society members.  For this project the instrument was used in a single 
organization at each of its clinical sites.  Despite the differences among size and sampling of the 
cohorts, certain similarities were observed.  The characteristics of the current sample were 
comparable when reviewing the average age and years of experience of the cohort studied by 
Polovich and Clark (2012). 
In Polovich and Clark‟s study (2012), nurses reported high levels of exposure knowledge, 
self-efficacy for the use of PPE, and perceived risk of harm from chemotherapy exposure.  
Despite these outcomes, Polovich and Clark noted that the total use of safety precautions for 
their population was quite low (an average of 1.9 in a range of 1 to 5).  These findings are similar 
to the responses of oncology nurses surveyed for the purposes of this practice project.  However, 
this cohort reported low levels of perceived risk to chemotherapy exposure and only moderate 
levels of self-efficacy for PPE use. 
 For this project, the cohort showed an inverse relationship (p < 0.05) between years of 
oncology experience and overall PPE use, not seen in the Polovich study (2012).  The results of 
this project suggest that the more years of oncology experience a nurse has the less likely he or 
she is to use personal protective equipment.  This may be explained somewhat by the evolution 
of PPE and fairly recent mandated compliance that may not be an established practice in older 
staff.  Nurses participating in this survey reported treating an average of 3 more patients (nearly 
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33% more) per nurse per day when compared to Polovich‟s sample.  Higher treatment volumes 
were associated with both lower self-efficacy for PPE use and more conflicts of interest in the 
workplace, remaining consistent with Polovich‟s previous findings.  However, in this study, data 
was not collected regarding the extent or duration of treatment that patients received, so specific 
nurse-patient ratio recommendations cannot be suggested until further information is gathered. 
  When comparing the current work to Polovich‟s study, certain relationships among 
variables were as expected.  That is, fewer perceived barriers and conflicts of interest, along with 
positive interpersonal influences were associated with perceptions of a better workplace safety 
climate and higher levels of self-efficacy regarding PPE use.  Of the scale variables, Polovich 
and Clark‟s research (2012) linked all but chemotherapy exposure knowledge to total precaution 
use, while the results of this project only found significant relationships between overall 
precaution use and interpersonal modeling.  Overall, many important similarities were observed 
between the groups despite their differences in composition.  Most of the findings of this project 
were consistent with previous literature (2012), although some relationships between variables 
that Polovich previously identified were not found to be statistically significant among survey 
respondents for this project. 
Application of Findings to Theoretical Frameworks 
The PARiHS framework facilitated the implementation of this project by acting as a 
reliable foundation to evaluate the progress and outcomes of the study (Kitson & Straus, 2010).  
Conceptually, context was explored by completing an assessment of the organization to 
investigate potential contributors to the practice problem and fully interpret the culture of safety 
in this setting.  Current evidence was reviewed to determine its applicability to this practice and 
key stakeholders within the organization were identified to act as project facilitators and 
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advocates.  The PARiHS framework provided an exemplary conceptual basis for reviewing 
evidence, context, and facilitators of safe chemotherapy handling practices of outpatient 
oncology nurses as well as guiding the successful translation of evidence in this setting. 
Donabedian‟s model was employed to examine healthcare services and assess quality of 
care issues for this project.  In this study, exploring the components of this framework led to a 
better understanding of the implications of the project‟s results and influenced potential 
recommendations for the organization.  Again, in Donabedian‟s framework, the concept of 
structure is associated with the organizational characteristics of the physical healthcare setting, 
while process involves the actual service provided.  The outcome is the end product.  
Structurally, the Chemotherapy Handling Questionnaire explored the availability of material 
supplies, patient volume, and characteristics of staff including education and years of experience.  
Relative to participants, most were middle-aged, certified in oncology nursing, and possessed a 
Bachelor‟s Degree in Nursing.  Respondents worked typical 10 hour days and saw an average of 
ten patients in that period of time.  The cohort had on average 19 years of nursing experience and 
14 years specialized in oncology nursing.         
 In general, this population was knowledgeable about chemotherapy exposure and 
reported moderate levels of self-efficacy for using personal protective equipment (PPE).  
However, they reported that chemotherapy-designated PPE was difficult to obtain and PPE was 
not always readily accessible.  These findings suggest that the presence or absence of these 
material supplies may be influencing perceived barriers to the safe administration of 
chemotherapy in this setting.   
 In regard to the process of chemotherapy administration, nurses reported moderate levels 
of perceived barriers to the use of PPE citing that it is physically uncomfortable (too hot), they 
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do not observe coworkers wearing PPE, and there is no policy that requires its use.  They also 
reported some conflict of interest associated with their inability to meet the needs of patients 
when using PPE and that patient care actually interferes with their ability to be fully compliant.  
The nurses also indicated they perceived a low risk of harm from chemotherapy exposure. 
When exploring the outcomes of the structures and process, it was noted that the use of 
chemotherapy-designated gloves was high; however, double gloving, the use of eye protection, 
and respirators were rarely utilized.  Despite high to moderate levels of education, self-efficacy, 
and years of experience of nursing staff, these variables did not impact their practice behavior.  
Thus, when applying Donabedian‟s theoretical framework to this practice project, the outcome 
was affected and the overall use of safety precautions was low.  Data analysis provided insight 
regarding Donabedian‟s concept of outcome, in that it was most impacted by years of oncology 
nursing experience (structure) and interpersonal modeling (process).  Although some variables 
did not have direct relationships with total precaution use, they did appear to influence each other 
and impact the overall perceptions of the workplace safety climate.    
Sustainability of the Project 
 Despite the availability of chemotherapy administration safety recommendations and the 
guidelines developed by professional organizations, best practice does not always produce 
optimal levels of adherence.  This truly highlights the importance of training and education for 
employers and workers, as well as the need for policy changes both nationally and locally.  
Workplace policies must be up to date and easily accessible to oncology nurses, while national 
safety guidelines need to become mandatory so they can be enforced in various health care 
settings.   
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This practice project has served as a pilot study to explore the safe-handling practice and 
knowledge levels of oncology nurses in a Midwest ambulatory care setting.  The findings have 
been effective in pointing to a multitude of direct education methods that may be implemented in 
the future to mitigate unnecessary chemotherapy exposure and improve the overall safety climate 
in this organization.  As the results of this project are generally consistent with previous research, 
it is presumed that it should be replicated with larger samples to gather further data regarding the 
safe administration of chemotherapy. 
After reviewing the data with managerial staff, the future direction that is taken with 
these results will depend on the mission and values of the organization and evolving national 
trends.  Key stakeholders will choose which recommendations to execute based on their 
feasibility and how they align with the organization‟s long-term goals.  This dissertation inquiry 
has provided a foundation for future efforts and provided a plethora of information to facilitate 
the development of further quality improvement projects to be determined by the organization.    
Doctor of Nursing Practice (DNP) Roles 
 The roles of the DNP have been significant in regard to the successful implementation of 
this project and the analysis of its findings.  The DNP as a clinician has had a distinct role in 
recognizing evidence based-practice guidelines and how they influence various aspects of care in 
the clinical setting.   Through leadership the DNP has established various relationships with key 
stakeholders and facilitators to enable the progression of this project and emphasize its 
importance.  The DNP as an advocate has a responsibility to improve the quality of care and 
safety of outpatient oncology nurses that are so often forgotten.    
 Through scholarship, the DNP reviews existing literature for applicability to the practice 
problem, identifies gaps between research and practice, and explores potential interventions.  As 
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an innovator, the DNP is required to evaluate the organization and implement the practice 
improvement process in a manner that corresponds to the needs, mission, and values of the site 
of interest.  The role of the DNP as an educator is to teach others about the significance of the 
practice problem and the need for change.  The educator role also develops appropriate 
educational recommendations for the clinic based on the results of the Chemotherapy Handling 
Questionnaire.     
Limitations 
 There were a number of limitations to this early, feasibility study.  The survey used a 
convenience sample of a single population in one organization and access to staff was through 
mailed communication.  The survey took approximately 20-30 minutes to complete and then 
needed to be mailed back to the primary investigator.  This may have been a barrier for 
individuals whose situation, for a variety of reasons, does not support access and response to 
mail.  The time needed to fill out the questionnaire may have been a deterrent as well.  To clarify 
the language of work status and eligibility a second mailing was sent to the entire sample.  This 
additional mailing was consistent with the Dillman method (Hoddinott & Bass, 1986), yet may 
have confused some respondents.  Furthermore, the sampling may have involuntarily solicited 
responses from only the more involved staff.   
 An additional limitation to this study was the previously established reliability and 
validity of the Chemotherapy Handling Questionnaire as related testing was not repeated for this 
study.  This may have resulted in some participants finding one or more questions unclear.  This 
is especially significant since the clinic uses non-disposable cloth lab coats rather than disposable 
gowns.  The survey contained multiple questions that asked whether the nurses wear „gowns‟ for 
chemotherapy handling activities and it did not distinguish between two common types of 
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gowns.   As a result, this may have unintentionally confused respondents relative to questions 
associated with gown-use. 
 The Hawthorne effect may have also influenced the results of the study (2007).  This 
effect may have manifested by participants changing their safe-handling behavior and 
compliance to standards simply because a questionnaire related to this topic was distributed.  
Other limitations of the study may have unintentionally encouraged participants to access 
evidence-based resources to better address survey questions and/or discuss the survey and its 
components with one another for comparison.     
 Lastly, while personal mean imputation is the most common imputation method utilized 
to address missing data, in some cases this technique can produce bias by artificially improving 
the psychometric qualities of survey scales (Hardouin, Conroy & Sebille, 2011).  In other words, 
personal mean imputation may influence results related to the participants‟ skills, knowledge, 
abilities and attitudes associated with the safe handling of chemotherapy.   
Recommendations 
 This safety improvement project has multiple implications for future research.  
Information associated with personal motivation for compliance with safe-handling standards 
needs to be evaluated.  This is especially significant, since project findings suggest that despite a 
high overall level of exposure knowledge and high perceived risk of exposure, total precaution 
use of outpatient oncology nurses may still be low.      
 Clinically, chemotherapy administration procedures need to be assessed to determine 
which barriers to safety can be minimized or eradicated and whether treatment volume may be 
reduced to improve outcomes and decrease the risk for unnecessary chemotherapy exposure.  
The organizational leaders need to ensure that appropriate PPE is readily available, and in 
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addition, improve communication regarding chemotherapy safety and organizational 
expectations for compliance.   
 Many participants perceived the lack of a safe-handling policy as a critical need in their 
work setting.  National chemotherapy administration guidelines should be reviewed in order to 
develop an appropriate work place policy based on current safety standards.  This policy should 
outline expected administration and disposal procedures and must be easily accessible to nursing 
staff.  The implementation of the Chemotherapy Handling Questionnaire and review of its 
findings should support the need for an ongoing evaluation of the safety climate in this 
organization and foster a culture that supports nurses and advocates for their needs in addition to 
their patients and the greater public. 
Conclusion 
 In 2012, Polovich and Clark published a study that evaluated the safe-handling practices 
of oncology nurses in a variety of clinics and hospitals across the United States.  Their research 
suggested that although nurses were well educated, experienced, and even certified in oncology 
their overall use of chemotherapy safety precautions was low.  Study outcomes also concluded 
that nurses employed by private, outpatient clinics had greater patient volumes than other 
settings (2012) and were less likely to use personal protective equipment when administering 
chemotherapy (Polovich & Martin, 2011).  The findings of this pilot study are consistent with 
previous research. 
 As the population of cancer patients and survivors grow, outpatient oncology clinics will 
be challenged to focus on the quality and safety of their work environments, patients, and the 
greater public; and surely not least of all, their nursing staff.  The DNP-prepared nurse is 
equipped to lead clinical safety improvement projects in the ambulatory care setting.  The 
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process of practice improvement has required the evolving abilities of the nurse as a clinician, 
leader, advocate, scholar, innovator and educator to lead important and necessary changes in the 
workplace.   
A knowledge deficit may contribute to current discrepancies in recommended practices, 
lack of compliance with chemotherapy administration standards, or contribute to poor overall 
awareness of one‟s personal risk for exposure and adverse outcomes.  Because of the significant 
risks, it is imperative that certain precautions are taken to reduce the risk of occupational injuries.  
This may involve altering work environments to improve safety, the use of necessary protective 
equipment, and modifying work place policies as needed.  This clinical problem demonstrates an 
opportunity for knowledge translation as there is an apparent gap between what is recommended 
for safe chemotherapy administration and what is actually practiced in the workplace. 
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APPENDIX A 
Letter of Permission – Polovich 
From:  Martha Polovich <martyp21@bellsouth.net> 
Sent:  Wednesday, March 26, 2014 at 8:04 AM 
To:  bouwkach@mail.gvsu.edu 
Subject: Re: Chemo safety 
 
Cheryl, 
 
I received your e-mail while I was away at a hazardous drug safe handling conference.  
I have read your prospectus. I have a few comments. 
 
1. “This project will explore whether this may be a result of a knowledge deficit, a lack of 
medical surveillance or other unforeseen impediments.” I don’t think medical 
surveillance has any influence on use of precautions. Do you have literature to support 
that? 
2. The ASCO/ONS Chemotherapy Safety Standards focus on patient safety and not related 
to occupational nurse exposure. There are currently no standards related to 
HD safety—only guidelines. 
3. Environmental contamination is not necessarily the result of nursing non-compliance 
with precautions. 
 
I am sending you the questionnaire used in my studies. Only one scale measures hazardous 
drug knowledge, and it is specific to chemotherapy exposure. The other scales measure 
variables identified in my literature review that are expected to influence HD precaution use. 
Precaution use is measured as the outcome variables. You have my permission to use the 
instrument except for one section. The interpersonal influence scales (Section 11) are adapted 
from Marjorie McCullough’s Farmers Social Norms and Social Modeling scales with permission. 
If you use them, you will have to obtain permission from her. 
  
Please cite the source of the instrument and share any reliability data. I hope that this is helpful 
to your project. 
  
Sincerely, 
  
Martha Polovich, PhD, RN, AOCN 
Clinical Associate Professor 
Byrdine F. Lewis School of Nursing and Health Sciences 
Georgia State University 
mpolovich2@gsu.edu 
404-408-3890 
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APPENDIX B 
Letter of Permission – McCullagh 
From: Marjorie McCullagh [mailto: mcculla@umich.edu]  
Sent: Friday, April 04, 2014 at 3:12 PM 
To:  bouwkach@mail.gvsu.edu 
Subject: consent to use instruments to measure factors influencing use of personal protective 
equipment 
 
Thank you for contacting me regarding use of my instruments. I am pleased to provide you with 
consent to use this in the way you have described, with acknowledgement in future 
presentations and publications.  Of course, I would be happy to answer any questions you 
might have about their use.  Best wishes on your project. 
Marjorie McCullagh, PhD, RN, PHCNS-BC, COHN-S 
Associate Professor and Director 
Occupational Health Nursing Program 
University of Michigan School of Nursing 
400 N. Ingalls St., Ste. 3182 
Ann Arbor, MI 48109 
Voice 734.763.3450 
Email mcculla@umich.edu 
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APPENDIX C 
Information Letter for Participants #1 
Dear CHCWM Nursing Colleagues, 
Thank you for taking the time to read this letter.  I am writing to ask your help in a study of 
oncology nurses being conducted for my doctoral dissertation.  This study is designed to 
explore the practices of outpatient oncology nurses in regard to the safe-handling of 
chemotherapy.   
In the next two weeks you will receive a parcel by mail.  The packet will contain a survey along 
with a postage-paid envelope.  Please take 20-30 minutes to complete the enclosed survey and 
return it by mail within 2 weeks of receipt. 
Your responses will be confidential and will be released only in summaries so that no 
individual’s answers can be identified.  No personal identifying data will be collected.  This 
survey is completely voluntary.  You can help me greatly by taking a few minutes to share your 
knowledge and experiences.  You can also let me know if you do not wish to participate by 
mailing back the uncompleted survey in the provided stamped envelope. 
All information collected by the survey will be password protected and stored in an electronic 
file at GVSU to maintain the protection of participants.  Results of the study will be available 
upon request following the completion of the project.  Participation in the survey will serve as 
your consent. 
If you have any questions or concerns about my research, please contact me either by phone or 
email and I will be happy to address your inquiries. 
Thank you for your time and participation, 
Cheryl Ann VerStrate, BSN, RN, OCN® 
Grand Valley State University 
Kirkhof College of Nursing 
616-502-6500 
bouwkach@mail.gvsu.edu  
cverstrate@chcwm.com 
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APPENDIX D 
Information Letter for Participants #2 
Dear CHCWM Nursing Colleagues, 
Thank you for taking the time to read this letter.  I am writing to ask your help in a study of 
oncology nurses being conducted for my doctoral dissertation.  This study is designed to 
explore the practices of outpatient oncology nurses in regard to the safe-handling of 
chemotherapy.   
Please take 20-30 minutes to complete the enclosed survey and return it by mail within 2 weeks 
of receipt in the postage-paid envelope provided.  
Your responses are completely confidential and will be released only in summaries so that no 
individual’s answers can be identified.  No personal identifying information is to be collected.  
This survey is voluntary.  You can help me greatly by taking a few minutes to share your 
knowledge and experiences.  You can also let me know if you do not wish to participate by 
mailing back the uncompleted survey in the enclosed stamped envelope. 
All information collected by the survey will be password protected and stored in an electronic 
file at GVSU to maintain the protection of participants.  Results of the study will be available 
upon request following the completion of the project.  Participation in the survey will serve as 
your consent. 
If you have any questions or concerns about my research, please contact me either by phone or 
email and I will be happy to address your inquiries.  If you have further questions regarding 
your rights as a participant contact the Human Research Office at GVSU via 616-331-3197 or 
email hrrc@gvsu.edu. 
Thank you for your time and participation, 
Cheryl Ann VerStrate, BSN, RN, OCN® 
Grand Valley State University 
Kirkhof College of Nursing 
616-502-6500 
bouwkach@mail.gvsu.edu or cverstrate@chcwm.com 
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APPENDIX E 
 
Letter of Clarification for Participants 
 
Dear CHCWM Nursing Colleagues, 
 
If you have taken the time to complete and return your survey, thank you for participating 
and please disregard the following communication to avoid the collection of duplicate data.   
 
If you did not complete the survey because you thought that only newly-hired nurses should 
participate, please review the packet and complete the corrected survey as appropriate.  
Return your responses in the postage-paid return envelope within 1 week of receipt.   
Once again, you can help me greatly by taking a few minutes to share your knowledge and 
experiences.  You can also let me know if you do not wish to participate by mailing back the 
incomplete survey in the enclosed stamped envelope. 
All information collected by the survey will be password protected and stored in an electronic 
file at GVSU to maintain the protection of participants.  Results of the study will be available 
upon request following the completion of the project.  Participation in the survey will serve as 
your consent. 
If you have any questions or concerns about my research, please contact me either by phone or 
email and I will be happy to address your inquiries.  If you have further questions regarding 
your rights as a participant contact the Human Research Office at GVSU via 616-331-3197 or 
email hrrc@gvsu.edu. 
Thank you again for your time and participation, 
 
Cheryl Ann VerStrate, BSN, RN, OCN® 
Grand Valley State University 
Kirkhof College of Nursing 
616-502-6500 
bouwkach@mail.gvsu.edu  
cverstrate@chcwm.com 
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APPENDIX F 
Approval from Grand Valley State University Human Research Review Committee 
DATE:   September 29, 2014   
   
 
TO:    Cheryl VerStrate, BSN, RN, OCN  
FROM:   Grand Valley State University Human Research Review Committee  
STUDY TITLE:  [638635-1] Exploration of Chemotherapy Safe-Handling Practices and  
Identification of Knowledge Deficits among Oncology Nurses in the 
Ambulatory Care Setting 
 
REFERENCE #:  15-036-H  
SUBMISSION TYPE: New Project   
 
ACTION:   APPROVED  
EFFECTIVE DATE:  September 29, 2014  
REVIEW TYPE:  Exempt Review 
 
Thank you for your submission of materials for your planned research study. It has been 
determined that this project: IS COVERED human subjects research* according to current 
federal regulations and MEETS eligibility for exempt determination under category 45 CFR 
46.101(b)(2).  
 
We do not have a letter of permission from the CHCWM; nor is there any discussion about 
IRB review from them (are they affiiliated with any IRB? Do they hold an FWA?). Please 
clarify. If they do not hold an FWA then the HRRC review and approval applies only to our 
DNP student.  
 
Exempt protocols do not require formal approval, renewal or closure by the HRRC. Any revision 
to exempt research that alters the risk/benefit ratio or affects eligibility for exempt review must 
be submitted to the HRRC using the Change in Approved Protocol form before changes are 
implemented.  
 
Any research-related problem or event resulting in a fatality or hospitalization requires 
immediate notification to the Human Research Review Committee Chair, Dr. Paul J. Reitemeier, 
616-331-3417 AND Human Research Protections Administrator, Mr. Jon Jellema, in the Office of 
the Provost, 616-331-2400. See HRRC policy 1020, Unanticipated problems and adverse events.  
 
Exempt research studies are eligible for audits.  
 
If you have any questions, please contact the Research Protections Program, Monday through 
Thursday, at (616) 331-3197 or rpp@gvsu.edu. The office observes all university holidays, and 
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does not process applications during exam week or between academic terms. Please include 
your study title and reference number in all correspondence with our office.   
 
*Research is a systematic investigation, including research development, testing and 
evaluation, designed to develop or contribute to generalizable knowledge (45 CFR 46.102 (d)) 
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APPENDIX G 
Letter of Approval from Immersion Site 
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APPENDIX H 
Chemotherapy Handling Questionnaire 
Chemotherapy Handling Questionnaire 
 
Thank you for agreeing to participate in this study of nurses who handle chemotherapy. “Handling” 
refers to chemotherapy preparation, administration, disposal, and coming into contact with patient’s 
excreta that may be contaminated with chemotherapy.  
 By preparation, we mean transferring chemotherapy drugs from vials or ampoules to syringes or IV 
containers.  
 By administration, we mean giving chemotherapy to patients by IV, injection, orally, etc. 
 By disposal, we mean discarding equipment used in chemotherapy preparation or administration. 
 By handling excreta, we mean emptying bedpans, urinals or emesis basins. 
 
 
Do you personally handle chemotherapy at work, either chemotherapy preparation or administration? 
 
 Yes  
 No  If you answered “No” STOP HERE and return the questionnaire in the enclosed postage-paid 
return envelope. 
 
 
Are you currently undergoing new-hire orientation? 
 
 Yes  If you answered “Yes” STOP HERE and return the questionnaire in the enclosed postage-paid 
return envelope. 
 No  
 
 
Before you proceed: 
 
1. Please read each item carefully. 
2. Please clearly mark your responses (as appropriate) from the options provided. 
3. Please respond to each question to the best of your ability describing your personal practice 
regarding chemotherapy administration. 
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Section 1 
Select one answer to each of the following statements about chemotherapy exposure. 
 True False 
Don’t 
Know 
1. Chemotherapy can enter the body through breathing it in 1 0 3 
2. Chemotherapy can enter the body through ingesting it 1 0 3 
3. Chemotherapy cannot enter the body through contact with 
contaminated surfaces 
1 0 3 
4. Chemotherapy can enter the body through contact with spills and 
splashes 
1 0 3 
5. Chemotherapy gas and vapor in air can enter the body through skin 
and mucous membranes 
1 0 3 
6. Oral forms of chemotherapy do not have the potential to be 
absorbed 
1 0 3 
7. Chemotherapy in liquid form can be absorbed through the skin 1 0 3 
8. A surgical mask provides protection from chemotherapy aerosols 1 0 3 
9. All types of gloves provide the same level of protection 1 0 3 
10. Chemotherapy can more easily enter the body through damaged 
skin 
1 0 3 
11. Alcohol hand sanitizer is as effective as soap and water in removing 
chemotherapy residue 
1 0 3 
12. Chemotherapy can enter the body through contaminated foods, 
beverages, or cosmetics 
1 0 3 
 
Section 2 
Indicate your level of agreement with each of these statements about using personal protective 
equipment (PPE) when handling chemotherapy. 
SA = Strongly Agree; A = Agree; D = Disagree; SD = Strongly Disagree: 
 SA A D SD 
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1. I am confident that I can use PPE properly 1 2 3 4 
2. I am confident that I can protect myself from chemotherapy exposure 1 2 3 4 
3. I am given enough information on how to protect myself from 
chemotherapy exposure 
1 2 3 4 
4. My supervisor goes out of his/her way to make sure I am protected 1 2 3 4 
5. Reuse of disposable PPE makes me feel less protected 1 2 3 4 
6. I am provided with the best available PPE 1 2 3 4 
7. My supervisor goes out of his/her way to make sure I am provided with 
proper fitting PPE 
1 2 3 4 
 
Section 3 
Does your workplace have written policies and/or procedures for handling chemotherapy? 
   Yes  
 No  
Where is chemotherapy prepared in your workplace? 
 Pharmacy 1 
Drugs are delivered to the infusion area (prepared in 
an off-site location) 
2 
 Specially designated room separate from the patient 
care area 
3 
 Area within the patient treatment area / room 4 
 Other (specify) 5 
 
 What personal protective equipment is available for performing the following 
chemotherapy handling activities? Check all that apply. 
  Gloves Gowns Eye  
Protection 
Respirator/ 
Mask 
 Preparation 1 2 3 4 
 Administration 1 2 3 4 
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 Handling Excreta 1 2 3 4 
 Disposal 1 2 3 4 
 Cleaning Spills  1 2 3 4 
 
 
Section 4  Chemotherapy Preparation: 
Are you responsible for preparing chemotherapy? 
 Yes    No  If you answered “No” proceed to Section 5. 
 
Complete this section ONLY if you prepare chemotherapy drugs.  
What type of gloves do you wear while preparing chemotherapy? 
 None   
 Chemotherapy designated gloves   
 Vinyl (polyvinyl chloride, PVC)   
 Latex examination gloves   
 Sterile surgical gloves   
 Other (specify) _____________ 
 
  
What type of protective clothing do you wear while preparing chemotherapy?  
(Check all that apply.) 
 None  
 Chemotherapy-designated gown   
 Personal lab coat   
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 Lab coat provided by office   
 Cloth gown   
 Isolation gown   
 Other (specify) ______________   
 
Please indicate how much of the time you use the following while preparing chemotherapy:  
 Always 76-99% 51-75% 26-50% 1-25% Never 
Biological Safety Cabinet 5 4 3 2 1 0 
Closed system transfer device 5 4 3 2 1 0 
Gloves labeled for use with 
chemotherapy 
5 4 3 2 1 0 
Other gloves (e.g. vinyl) 5 4 3 2 1 0 
Double gloves 5 4 3 2 1 0 
Gowns labeled for use with 
chemotherapy 
5 4 3 2 1 0 
Other gowns (e.g. cloth) 5 4 3 2 1 0 
Do you re-use disposable gowns? 5 4 3 2 1 0 
Eye protection 5 4 3 2 1 0 
Respirator/mask 5 4 3 2 1 0 
   
Section 5 Chemotherapy Administration:  
Are you responsible for administering chemotherapy? 
 Yes   No   If you answered “No” proceed to Section 6. 
Complete this section ONLY if you administer chemotherapy.  
What type of gloves do you wear while administering chemotherapy? 
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 None   
 Chemotherapy designated gloves   
 Vinyl (polyvinyl chloride, PVC)   
 Latex examination gloves   
 Sterile surgical gloves   
 Other (specify) ___________   
What type of protective clothing do you wear while administering chemotherapy?  
Check all that apply. 
 None   
 Chemotherapy-designated gown   
 Personal lab coat   
 Lab coat provided by office   
 Cloth gown   
 Isolation gown   
 Other (specify) _____________   
 
Please indicate how much of the time you use the following while administering chemotherapy 
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 Always 76-99% 51-75% 26-50% 1-25% Never 
Closed system transfer device 5 4 3 2 1 0 
Gloves labeled for use with chemotherapy 5 4 3 2 1 0 
Other gloves (e.g. vinyl) 5 4 3 2 1 0 
Double gloves 5 4 3 2 1 0 
Gowns labeled for use with chemotherapy 5 4 3 2 1 0 
Other gowns (e.g. isolation) 5 4 3 2 1 0 
Do you re-use disposable gowns? 5 4 3 2 1 0 
Eye protection 5 4 3 2 1 0 
Respirator/mask 5 4 3 2 1 0 
 
 
Section 6 Chemotherapy Disposal: 
Are you responsible for disposing of chemotherapy? 
 Yes    No  If you answered “No” proceed to Section 7. 
Complete this section ONLY if you dispose of chemotherapy.  
Please indicate how much of the time you use the following when disposing of chemotherapy: 
 77 
 
 Always 76-99% 51-75% 26-50% 1-25% Never 
Gloves labeled for use with chemotherapy 5 4 3 2 1 0 
Other gloves (e.g. vinyl) 5 4 3 2 1 0 
Double gloves 5 4 3 2 1 0 
Gowns labeled for use with chemotherapy 5 4 3 2 1 0 
Other gowns (e.g. isolation) 5 4 3 2 1 0 
Do you re-use disposable gowns? 5 4 3 2 1 0 
Eye protection 5 4 3 2 1 0 
Respirator/mask 5 4 3 2 1 0 
 
 
Section 7 Handling Contaminated Excreta: 
Are you responsible for handling chemotherapy-contaminated excreta? 
 Yes    No  If you answered “No” proceed to Section 8. 
Complete this section ONLY if you handle chemotherapy-contaminated excreta.  
Please indicate how much of the time you use the following when handling excreta:  
 Always 76-99% 51-75% 26-50% 1-25% Never 
Gloves labeled for use with chemotherapy 5 4 3 2 1 0 
Other gloves (e.g. vinyl) 5 4 3 2 1 0 
Double gloves 5 4 3 2 1 0 
Gowns labeled for use with chemotherapy 5 4 3 2 1 0 
Other gowns (e.g. isolation) 5 4 3 2 1 0 
Do you re-use disposable gowns? 5 4 3 2 1 0 
Eye protection 5 4 3 2 1 0 
Respirator/mask 5 4 3 2 1 0 
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Section 8 
Are chemotherapy spill kits available in your work area?  Yes   No  
During the most recent chemotherapy spill in your workplace, 
did you use the materials in the spill kit? 
 Yes   No   N/A  
Please write the name of three chemotherapy drugs that you handle most frequently: 
Drug1___________________________________________  
Drug2___________________________________________ 
Drug3___________________________________________ 
Section 9 
Indicate your level of agreement with each of the following statements. 
SA = Strongly Agree; A = Agree; D = Disagree; SD = Strongly Disagree: 
Some reasons that I may not wear PPE 
regularly when handling chemotherapy 
are: 
SA A D SD 
1. I don’t think PPE is necessary  
4 3 2 1 
2. I don‟t think PPE works  
4 3 2 1 
3. I don‟t have the time to use PPE 
4 3 2 1 
4. I was not trained to use PPE  
4 3 2 1 
5. PPE is uncomfortable to wear  
4 3 2 1 
6. PPE makes it harder to get the job 
done  
4 3 2 1 
7. PPE is not always available  
4 3 2 1 
8. Others around me don‟t use PPE  
4 3 2 1 
9. There is no policy requiring PPE  
4 3 2 1 
10. People would think I am overly 
cautious  
4 3 2 1 
11. It is hard to get chemotherapy-
designated PPE  
4 3 2 1 
12. PPE is too expensive to use it all the 
time  
4 3 2 1 
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13. PPE makes me feel too hot  
4 3 2 1 
  
Section 10 
Indicate your level of agreement with each of the following statements about the risks of chemotherapy 
exposure. 
SA = Strongly Agree; A = Agree; D = Disagree; SD = Strongly Disagree: 
 SA A D S
D 
1. Exposure to chemotherapy is a serious problem at work 4 3 2 1 
2. I am concerned about chemotherapy exposure at work and how it might affect 
my health 
4 3 2 1 
3. Compared to co-workers, my chance of harm from chemotherapy exposure is 
lower 
4 3 2 1 
4. If exposed to chemotherapy, there is a real chance that I might experience bad 
effects 
4 3 2 1 
5. Chemotherapy exposure is not as harmful as some people claim 4 3 2 1 
6. Compared to other work-related health risks, chemotherapy exposure is less 
serious 
4 3 2 1 
7. I am not worried about future negative health effects from chemotherapy 
exposure 
4 3 2 1 
 
Section 11 
How often do the following people wear personal protective equipment when handling 
chemotherapy? 
 Never Sometimes 
About  
Half 
Usually 
Does not 
apply 
Your co-workers 0 1 2 3 4 
Other nurses you know 0 1 2 3 4 
Oncology nurses in general 0 1 2 3 4 
 
According to the following people, how important is wearing PPE when handling chemotherapy?  
 Not at all Sort Of Very Does not  
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important important important apply 
Your co-workers 0 1 2 3 
Other nurses you know 0 1 2 3 
Your supervisor or 
manager 
0 1 2 3 
Your employer 0 1 2 3 
 
Section 12 
Indicate your level of agreement with each of the following statements. 
SA = Strongly Agree; A = Agree; D = Disagree; SD = Strongly Disagree: 
 SA A D SD 
1. Personal protective equipment keeps me from doing my job to the best 
of my abilities. 
4 3 2 1 
2. Wearing personal protective equipment makes my patients worry. 4 3 2 1 
3. Patient care often interferes with my being able to comply with using 
precautions. 
4 3 2 1 
4. I cannot always use safe handling precautions because patient‟s needs 
come first. 
4 3 2 1 
5. Sometimes I have to choose between wearing PPE and caring for my 
patients 
4 3 2 1 
6. Wearing personal protective equipment makes my patients feel 
uncomfortable. 
4 3 2 1 
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Section 13 
Indicate your level of agreement with these statements regarding safety in your work place: 
SA = Strongly Agree; A = Agree; N = Neutral; D = Disagree; SD = Strongly Disagree: 
  SA A N D SD 
 1. Chemotherapy gloves are readily accessible in my work area 5 4 3 2 1 
 2. Chemotherapy gowns are readily available in my work area 5 4 3 2 1 
 3. The protection of workers from occupational exposure to chemotherapy is 
a high priority with management where I work 
5 4 3 2 1 
 4. On my unit, all reasonable steps are taken to minimize hazardous job tasks 5 4 3 2 1 
 5. Employees are encouraged to become involved in safety and health 
matters 
5 4 3 2 1 
 6. Managers on my unit do their part to insure employees’ protection from 
occupational exposure to chemotherapy 
5 4 3 2 1 
 7. My job duties do not often interfere with my being able to follow 
chemotherapy safe handling precautions 
5 4 3 2 1 
 8. I have enough time in my work to always follow chemotherapy safe 
handling precautions 
5 4 3 2 1 
 9. I usually do not have too much to do so that I can follow chemotherapy 
safe handling precautions 
5 4 3 2 1 
 10. On my unit, unsafe work practices are corrected by supervisors 5 4 3 2 1 
 11. My supervisor talks to me about safe work practices 5 4 3 2 1 
 12. I have had the opportunity to be properly trained to use personal 
protective equipment so that I can protect myself from chemotherapy 
exposures 
5 4 3 2 1 
 13. Employees are taught to be aware of and to recognize potential health 
hazards at work 
5 4 3 2 1 
 14. In my work area, I have access to policies and procedures regarding safety 5 4 3 2 1 
 15. My work area is kept clean 5 4 3 2 1 
 16. My work area is not cluttered 5 4 3 2 1 
 17. My work area is not crowded 5 4 3 2 1 
 18. There is minimal conflict within my work area 5 4 3 2 1 
 19. The members of my work area support one another 5 4 3 2 1 
 20. In my work area, there is open communication between supervisors and 
staff 
5 4 3 2 1 
 21. In my work area we are expected to comply with safe handling policies and 
procedures 
5 4 3 2 1 
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Section 14 
What is your highest level of NURSING education? 
(1) Diploma (3) Bachelor’s degree (5) Doctoral Degree 
(2) Associate degree (4) Masters degree  
 
Are you a member of the Oncology Nursing Society (ONS)? 
(1) Yes  (2) No 
 
Are you ONS certified to administer chemotherapy and biotherapy? 
(1) Yes  (2) No 
Are you certified in nursing? 
(1) Not certified (3) AOCN® (5) NP (7) Other _______ 
(2) OCN® (4) AOCNS® (6) AOCNP®  
 
Please enter the number requested: 
Your age in years:    
Years of nursing experience:    
Years of oncology nursing experience:    
Years of chemotherapy handling experience:    
Number of patients for whom you personally 
administer chemotherapy per day: 
   
Number of patients receiving chemotherapy per 
day at your work place: 
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Is there anything else you would like to tell us about safe handling in your work place? 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thank you for participating in this study! 
 
Please Note: This survey was originally developed by Dr. Martha Polovich.  The instrument was used and adapted 
with permission for the purposes of this practice inquiry. 
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